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Abstract
Protein restriction (low protein, LP) during fetal and neonatal life has been shown in
our laboratory to alter the normal development of the pancreas, resulting in predisposition to
glucose intolerance and striking gender differences in key insulin signaling molecules. The
objectives of this study were to examine the overall expression of Pdxl and its downstream
target genes in young and adult rats (d21and d l30) and to investigate the intrinsic molecular
mechanisms that may be involved in the differentiation and function of P-cells when an insult
such as dietary protein content is changed during different periods of early development.
Pregnant Wistar rats given control diet (C, 20% protein) or low protein diet (LP, 8%
protein) were separated into four groups: C group (fed with C diet all life), LP1 group (fed
with LP diet all life), LP2 group (fed with LP diet during gestation and lactation and C diet
after weaning) and LP3 group (fed with LP diet during gestation only, and C diet thereafter).
Eight mothers were used per group. Offspring from each mother, one male and one female,
were sacrificed at d21 and at dl30 and their pancreata were collected. RNA was extracted
and analyzed by quantitative real time PCR (qRT-PCR) and protein analysis was performed
by Western blot.
Data obtained from qRT-PCR showed that Pdxl gene expression did not change in
males in all LP groups as compared to control group at d21. At dl30, the C group showed a
significant increase in Pdxl gene expression as compared to C group of d21 age group.
Interestingly, LP groups did not show such significant changes over time as compared to d21
C group. When the levels of Pdxl gene expression in LP groups at d 130 were compared to
the C group at the same age, it appears that the expression of the gene and protein was
iii

significantly decreased (p<0.05) suggesting an inhibition of the age-dependent increase in
Pdxl in male rats by LP diet treatment. On the other hand, protein abundance of downstream
target genes including insulin, glucokinase (GK) and GLUT2 did not change in male
offspring within LP groups compared with C at d21. At d l30; however, insulin gene and
protein were also significantly decreased in LP1 and LP3 males compared to C, but did not
change in LP2. Other downstream target genes including GLUT2 gene and protein levels
were significantly decreased in LP3 group only, while GK did not change in all groups
compared to control at dl30. We also observed that in females Pdxl expression and protein
and its downstream target gene did not change by LP treatments at d21 or dl30. Intraperitoneal glucose tolerance test (IGTT) also showed a significant impairment in males of the
LP3 group. Therefore, we examined the morphometry of the pancreas in the LP3 males,
which showed that (3-cell mass, (%) islet area and (%) (3-cells area were significantly
decreased in this group compared to the control.
The presented data show that nutritional imbalance correlates with changes in Pdxl
transcription factor gene expression patterns that can alter (3-cell development. It also
contributes to further understanding of the molecular basis of fetal programming. This could
provide a unique opportunity to develop new strategies for treatment of chronic diseases such
as diabetes mellitus in the future.

Key words
Diabetes Mellitus, development o f the pancreas, fetal origin o f adult diseases, low protein
diet, Pdxl transcription promoter.
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Chapter 1: INTRODUCTION

1.1. Fetal development
The normal development of the baby or offspring starts in utero and has two important
phases: the first phase, the embryonic life that consists of proliferation, organization and
differentiation of the embryo and represents the first 8 weeks of pregnancy in humans and 7-8
days in rodents (Rappaport 1993; Gardner 2001); and the second phase, the fetal life which
consists of continued growing and functional maturation of different tissues and organs and
starts from the end of the 8th week to the end of pregnancy. Completion of these stages is
important for the fetus to be able to survive at birth (Rappaport 1993; Gardner 2001; Carlson
2004). These two phases can determine the susceptibility of the neonate at birth and later in
adulthood to health problems (Barker 1998). In humans, differentiation of body structures and
maturation of organ function occurs during the early fetal period (9 to 20 weeks); at the 16th
week, the embryo weighs 20 g, while after 20 weeks (24-25 weeks) the fetus weighs 650 to 780
g (Carlson 2004). From week 29 to term, fat and muscle tissue and skin thickness increase, and
at week 38 to 40 the average weight is 3000 to 3800 g (Moore and Persaud 2003). Therefore, in
humans the third trimester is very important for fetal maturation and growth (Moore and Persaud
2003). Moreover, Painter and his group have shown that maternal nutrient restriction during late
gestation has more impact on birth weight than at mid gestation (Painter, Roseboom et al. 2005).
On the other hand, in rodents, many organs are not totally mature at birth; the neonatal period
acts as an extension of the prenatal period and is necessary for further organ differentiation and
maturation (Petrik, Arany et al. 1998; Butler, Janson et al. 2003).
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These periods of development and growth are determined and influenced by multiple
factors. Some of these factors are related to the conceptus such as genetic output of the embryo
and others are related to the maternal health that will provide for the intrauterine environment.
The interaction between the fetus and the mother occurs through the matemo-placento-fetal unit
that controls the level of nutrients and oxygen supply to the fetus (Gluckman and Harding 1994;
Kanaka-Gantenbein, Mastorakos et al. 2003). Therefore, there is a tight connection between
maternal and fetal health and predisposition to disease later in life.

1. 1. 1.

Fetal programming
The concept of ‘fetal programming’ is used to describe how an insult or a stimulus

during a critical or sensitive period of fetal development results in long-term effects on the
organism (Ozanne and Constancia 2007). It may occur at the time when fetal development is
plastic or the fetus is experiencing rapid cell proliferation (McCance and Widdowson 1974). The
critical period also varies for different organ systems, and consequently, developmental
programming could occur at various times including conception, fetal life and infancy (Ozanne
and Constancia 2007). Therefore, any nutritional challenges during pregnancy in early-, mid- or
late-gestation will have different effects on the placenta and fetal weight and this has been
demonstrated in rodents (Villar and Belizan 1982; Chamson-Reig, Thyssen et al. 2006).
Epidemiological studies in human have suggested an association between poor fetal or infant
growth due to adverse intrauterine conditions and increased risk of developing glucose
intolerance (type 2 diabetes mellitus, T2DM) and metabolic syndrome later in life (Hales, Barker
et al. 1991; Hales and Barker 2001). Figure 1.1 summarizes this hypothesis and shows that fetal
exposure to an unhealthy environment such as maternal stress, infection, undemutrition (by
reduced calorie intake and/or altered dietary composition), placental dysfunction, addiction to
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recreational drugs, smoking, and alcohol consumption programs the fetus to adapt to this
environment and may result in small for gestation age (SGA) offspring and predisposition to
long-term metabolic disorders (Barker, Gluckman et al. 1993). This hypothesis was previously
called ‘fetal origins and adult disease’ (Barker 1995), and later called ‘developmental origins o f
adult health and disease’ (Barker 2004; McMillen and Robinson 2005).

1.1.2.

Environmental factors that affect fetal developments
A large number of animal models have been used to study the effect of environmental

factors during fetal growth and adult disease. Malnutrition during pregnancy results in babies
with low birth weight (LBW) and an increase risk of neonatal mortality and morbidity
(Shrimpton 2003). In addition, maternal hypoxia or utero-placental insufficiency by uterine
artery ligation have been linked to intrauterine growth retardation (IUGR), LBW and
cardiovascular disease in offspring (Wigglesworth 1974; Chvojkova, Ostadalova et al. 2005).
Studies in this model have also shown a reduction in Pdxl expression and p-cell proliferation,
disturbance in the development of the pancreas (De Prins and Van Assche 1982) Staffers, Desai
et al. 2003; Styrud, Eriksson et al. 2005), glucose intolerance with insulin resistance, insulin
secretory defect and marked hyperglycaemia early in life (Simmons, Templeton et al. 2001;
Vuguin, Raab et al. 2004) as well as gender-specific development of hypertension in later life
(Moritz, Mazzuca et al. 2009). Moreover, excessive maternal exposure to glucocorticoids can
result in intra-uterine growth retardation (IUGR) in both humans and animals with alteration in
the rate of organ maturation and increasing risk to developing glucose intolerance, insulin
resistance, hypertension and hypothalamic-pituitary-adrenal (HPA) axis hyperactivity (Nyirenda,
Lindsay et al. 1998; Reynolds, Walker et al. 2001; Doyle, Faber et al. 2003; Seckl and Meaney
2004; de Vries, Holmes et al. 2007). Maternal iron insufficiency has been linked in

Figure 1.1: Schematic representation illustrating the thrifty phenotype hypothesis
proposed by Barker. Challenges to the developing fetus through changes in the intrauterine
environment including nutritional and other types of insults can have a strong impact on the fetal
birth weight and general health later in life. (From: Femandez-Twinn and Ozanne, 2006)
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different models to maternal and fetal complications, such as decreased placenta vascularization
and degradation of maternal and fetal hormones, which lead to preterm birth and pre-clampsia
(Rasmussen 2001; Breymann 2002). Besides causing LBW in offspring, iron deficiency during
pregnancy also causes hypertension in offspring in early life (Lewis, Petry et al. 2001; Lewis,
Forhead et al. 2002; Gambling, Dunford et al. 2003).
Maternal calorie restriction in rats, dietary modifications in early life, such as altered
composition, excess or restricted intake, during pregnancy also leads to LBW, (3-cell dysfunction
and age dependent loss of glucose tolerance (Garofano, Czemichow et al. 1999) in rodent
models (Alvarez, Martin et al. 1997; Garofano, Czemichow et al. 1997; Petrik, Reusens et al.
1999; Chamson-Reig, Thyssen et al. 2006; Chamson-Reig, Thyssen et al. 2009).

1.1.3.

Maternal protein restriction.
Maternal low protein diet (LP) is an extensively studied rodent model of intrauterine

insult and results in LBW offspring (Ozanne and Hales 1999). Feeding LP diet to pregnant rats
causes high blood pressure (Langley and Jackson 1994) and renal impairment in the offspring
(Langley-Evans, Welham et al. 1999). Rats exposed to LP diets in utero have increased
morbidity and mortality rates with shorter lifespan (Aihie Sayer, Dunn et al. 2001), altered
glucose homeostasis (Femandez-Twinn and Ozanne 2006), vascular dysfunction ,
hypertriglyceridemia and hypercholesterolemia (Torrens, Brawley et al. 2006; Erhuma, Salter et
al. 2007). LP diet during gestation results in dysfunction in the endocrine pancreas in the rat
offspring manifested by reduced (1-cells mass and insulin content (Snoeck, Remade et al. 1990).
Previously, our laboratory has shown that LP diet given during pregnancy at different windows
of development had different effects on the endocrine pancreas including decrease in P-cell mass
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and islet cell area with failure to develop large islets and low pancreatic insulin content
(Chamson-Reig, Thyssen et al. 2006; Chamson-Reig, Thyssen et al. 2009). Our laboratory and
others have shown that reduction of protein content to 8% in an overall isocaloric diet (LP)
throughout gestation resulted in a moderate intrauterine growth restriction and reduced
pancreatic weight in offspring at birth (Reusens, Dahri et al. 1995; Hales and Ozanne 2003;
Guan, Arany et al. 2005). Morphometrical changes such as reduced P-cell mass, islet area and
pancreatic vascularity with increased cell apoptosis and decreased rate of P-cell duplication were
also examined and found to be irreversible (Petrik, Reusens et al. 1999; Boujendar, Arany et al.
2003). In addition, studies have shown that if LP diet is extended into neonatal life, the pancreas
would show an impaired response when challenged with a control diet (C) of 20% protein
content and these animals will develop insulin resistance in adult life (at 15 months of age) in
males and later (at 21 months of age) in females (Ozanne, Olsen et al. 2003; Femandez-Twinn
and Ozanne 2006).
In our experience, impairment of glucose homeostasis starts at 130 days in offspring
exposed to LP diet during gestation and/or lactation with striking sexual dimorphisms in key
insulin signaling pathways in adipose tissue and skeletal muscle (Chamson-Reig, Thyssen et al.
2006). In light of these findings, we can conclude that LP diet during gestation and/or lactation
can program the developing fetus to develop chronic diseases such as T2DM later in adulthood.

1.2. Diabetes mellitus (DM)
Diabetes mellitus (DM) is considered to be a major threat to public health where it
affects more people every year. It is a metabolic disease characterized by hyperglycemia and
disturbance in carbohydrate, protein and fat metabolism due to deficiency of insulin secretion or
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action or both. Diabetes leads to several complications such as retinopathy, nephropathy, and
polyneuropathies with loss of limbs, cardiovascular disease and reduced life expectancy. It was
estimated in 2009 by the International Diabetes Federation that 285 million people worldwide
have diabetes, 80% of whom live in less developed countries and this number is expected to
reach 438 million by the year 2030 (International Diabetes Federation, 2009).

1.3. Classification of diabetes
There are several distinct types of DM that are caused by a complex interaction of
genetic and environmental factors. DM is classified on the basis of the pathogenic process that
leads to high blood glucose. It involves criteria such as the age of onset or type of treatment
required. The most recent classification for DM by the WHO is as following: (1) Type 1
Diabetes Mellitus (T1DM), (2) Type 2 Diabetes Mellitus (T2DM), (3) others types and (4)
gestational diabetes (George and Alberti 2010).

1.3.1.

Type 1 diabetes mellitus (T1DM)
Type 1 Diabetes Mellitus (T1DM) results from idiopathic or autoimmunological p-cell

destruction, leading to absolute insulin deficiency. It represents about 5%—10% of all cases of
diabetes and most often diagnosed in children and adolescents, with the major susceptibility
gene mapping to the HLA region of chromosome 6. According to the WHO, Type 1A is an
autoimmune T1DM, and the non-auto immune T1DM is called type IB (George and Alberti
2010). T1DM patients depend on multiple daily exogenous intensive insulin injection therapy or
insulin- administering pump to help to control their blood glucose (Slack 1995).
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1.3.2.

Type 2 diabetes mellitus (T2DM)
Type 2 DM, (T2DM), is the most common form of diabetes representing about 90% of

the cases. It affects 10%-20% of those older than 45 years of age in many developed countries
and is recently becoming more prominent in younger individuals. The main characteristic of
T2DM is the variable degree of insulin deficiency and peripheral insulin resistance leading to
increase in plasma glucose level (hyperglycaemia). The etiology of T2DM is not well
understood although several environmental and genetic factors are thought to be involved in 13cell function impairment and peripheral insulin resistance in muscles, fat tissue and hepatocytes
(Bouchard 1995; Targher, Alberiche et al. 1997; Gerich 1998).
Impaired glucose tolerance test (IGT) and impaired fasting glycaemia (IFG) represent a
clinical stage in development of T2DM (Shaw, Zimmet et al. 1999; de Vegt, Dekker et al. 2001).
In addition, T2DM has been shown to be presented following IGT (Knowler, Barrett-Connor et
al. 2002; Chamson-Reig, Thyssen et al. 2009). The diagnostic criteria recommended by WHO
for diabetes is when fasting plasma glucose > 7.0mmol/L is maintained over 2xweeks, or, 2h
after ingestion of 75g oral glucose load, the plasma glucose remains at > 1 l.lmmol/L (WHO
1994). It is estimated that about 344 million or 7.9% in the 20-79 age group had IGT in 2010
(George and Alberti 2010).
Many studies have shown that good diet and exercise markedly decreases the onset of
diabetes in persons with IGT (Pan, Li et al. 1997; Tuomilehto, Lindstrom et al. 2001; Knowler,
Barrett-Connor et al. 2002). T2DM can be caused by environmental stresses, including
advancing age, pregnancy, obesity (specially central obesity), inactivity, dietary excess fat and
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carbohydrate and factors such as positive family history of T2DM, gestational diabetes mellitus
(GDM), hypertension and hyperlipidemia (Leahy 1990).
Defects in P-cell function are quite obvious by the time T2DM is diagnosed. Increase in
P-cell mass is a part of the normal P-cell compensation to normalize glycaemia. After that,
studies have shown a major reduction in P-cell mass and higher levels of P-cell apoptosis
(Butler, Janson et al. 2003; Yoon, Ko et al. 2003). Failure of P-cells to compensate for the lack
of insulin, results in the development of T2DM (Bonner-Weir 2000). The main function of Pcells is to regulate glucose level in blood by secreting insulin. Insulin secretion is biphasic; the
first phase occurs within 10 minutes of glucose intake and the second phase reaches a steady
state very quickly in mice and in 2-3 hours in rats and humans (Gerich 2002). The defect in the
first phase of insulin secretion is showed in IGT (Calles-Escandon and Robbins 1987; Luzi and
DeFronzo 1989), while the defects in both phase 1 and phase 2 are considered the earliest signs
in T2DM (Gerich 2002). Some patients are treated with oral hypoglycaemic medications to
improve insulin release, insulin sensitivity and reduce glucose production by the liver (DeFronzo
and Ferrannini 1991; Blonde 2009). Oral hypoglycaemic medication such as sulfonylureas
(insulin secretagogues) are used to stimulate the P-cells to release insulin (Blonde 2009). Also,
biguanides and thiazolidinediones (insulin sensitizers) work to improve insulin sensitivity and to
reduce the glucose produced by the liver (Blonde 2009). Acarbose prolongs the absorption of
carbohydrates after a meal. Glucagon-like peptide-1 (GLP-1) analogs, a class of medications that
include liraglutide, helps P-cells release insulin and reduces the release of glucose from the liver.
Dipeptidyl peptidase-4 inhibitors, a class of medications that increases the half-life of GLP-1,
improves insulin release and decreases glucose release from the liver (Blonde 2009). When
T2DM patients do not respond to any of these medications, insulin treatment is recommended.
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More than 50% of people with T2DM will require insulin injections in their lifetime.
Nowadays, at least 2 million patients with T2DM in United States are treated with daily insulin
injection (Porte, Sherwin et al. 2003; Mayfield and White 2004).

1.3.3.

Other types o f diabetes
The other types of diabetes are related to genetic defects of pancreatic P-cell function

e.g., maturity- onset diabetes of the young (MODY). It is a monogenic autosomal dominant
disease and is characterized by defects in insulin secretion causing an early onset of T2DM
usually before 25 years of age, commonly in childhood or adolescence (Velho and Froguel
1998). The prevalence of MODY is estimated about 1-2% in patients with T2DM (Ledermann
1995). It can result from mutations in any one of the following 6 genes in the beta cell:
hepatocyte nuclear factor 4 (MODY1), HNF alpha (MODY3), Pdbc-1 (MODY4), HNF1J3
(MODY5), BETA2 (MODY6) and GK (MODY2) (Froguel, Vaxillaire et al. 1992; Ledermann
1995; Yamagata, Furuta et al. 1996; Stoffers, Ferrer et al. 1997).
V
1.3.4.

Gestational diabetes
There is another type of diabetes that is diagnosed or detected first during pregnancy and

is called ‘gestational diabetes’ (GDM). Screening for GDM is generally undertaken at around
28 weeks. There is significant morbidity associated with GDM including fetal death, congenital
malformation, neonatal hypoglycaemia, jaundice, prematurity and macrosomia.

1.4. Anatomy and physiology of the pancreas
The pancreas is an elongated gland located in the abdominal cavity (Figure 1.2), just
caudal to the stomach and opposite to the liver along the gastro- intestinal-tract (GIT). The
human pancreas has three parts: the head, which is the proximal portion, lies in the crook of
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duodenum; and the tail, which is the distal portion that contacts the spleen and body of the
stomach. In rodents the shape of the pancreas is less defined. The pancreas plays a crucial
function in maintaining nutritional homeostasis through the synthesis/secretion of enzymes and
hormones. The mammalian pancreas includes three different cellular compartments: the
endocrine cells (islets of Langerhans) which are hormone-secreting, the exocrine cells (acinar)
which are digestive or hydrolytic enzyme-secreting, and the ductal cells that deliver enzymes
produced by pancreas cells into the duodenum (Slack 1995).
The exocrine cells (acinar) comprise about 90% of the pancreatic gland; they produce
digestive enzymes such as protease, amylases, nucleases and lipases that are secreted into the
duodenum through the pancreatic duct, which forms an elaborately branched network of
tubules composed of epithelial ductal cells (Githens 1994). The endocrine cells are small
spherical cluster cells grouped in the islet of Langerhans comprising around 2-3% of the total
pancreatic volume. Islet cells produce hormones that are involved in glucose homeostasis by 5
types of cells: beta-cells which secrete insulin and represent 60 -80% of adult iklet cells
depending on species; alpha (a) cells which secrete glucagon and represent 20-30 % of islet
mass; delta (5) cells which secrete somatostatin and represent 10% of islet mass; pancreatic
polypeptide cells (PP) which produce pancreatic polypeptide and represent less than 5% of islet
mass and epsilon cell (s) which produce ghrelin which is related to appetite stimulus and
represent less than 1% of islet mass (Figure 1.3) (Slack 1995; Heller, Jenny et al. 2005).
In rodents the majority of p-cells are in the center core of the islet surrounded by a
mantle of a cells and 8 cells; however, human islets show less organization with a cells and 8

Figure 1.2: Anatomical structure and localization of human pancreas. From Mckinley, M.
and O’Loughlin VD. Human Anatomy 2nd Edition, 2003.
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cells (Cabrera, Berman et al. 2006). Islets are highly vascularised and receive about 15% of the
pancreatic blood supply. The arterial blood supply starts penetrating the mantle and forms a
capillary bed in the center core so the major route of blood supply flows from P-cells to the
mantle a and 8 cells (Bonner-Weir 2000).

1.5. Development of the pancreas in utero: Comparison between human and
rodents
The pancreas develops similarly in all mammals, but the sequence of stages may vary
from one species to another. Human pancreas formation and development is similar to that in
the mouse as depicted in Figure 1.4. The main difference between human and mice pancreatic
development is in the final commitment of the organ (Pan and Wright 2011). In humans, the
third trimester of pregnancy is crucial to pancreatic development. At this time, it undergoes a
process of remodeling and maturation making it able to respond to nutrients at birth (Green,
Rozance et al. 2010). In mice and rats, development of the pancreas continues after birth; the
lactation period constitutes an important phase in these animals as they undergo a process of
remodeling by which fetal-like cells are replaced by new more mature P-cell, a process that
occurs post-natal between dlO-14 (Kaung 1994; Finegood, Scaglia et al. 1995; Petrik, Arany et
al. 1998). Proliferation rate of P-cells is high at birth (around 18 %) and then rapidly decreases at
neonatal age in rats (Finegood, Scaglia et al. 1995; Slack 1995; Bonner-Weir 2000; Green,
Rozance et al. 2010). In rodents it has been also shown that after weaning new islets are formed
in a second wave of neogenesis (Bonner-Weir 2000).
Although previous research claimed that pancreatic endocrine cells are derivatives from
ectoderm and exocrine cells are derivatives from endoderm, it is now generally known that
both exocrine and endocrine cells arise from epithelial endodermal origins
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Figurel.3: Schematic representation of pancreatic structure.
(http://health.howstuffworks.com/diseases-conditions/diabetes/diabetesl.htm, accessed June 24,
2011)
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Figure 1.4: Time line comparing different stages of mouse and human pancreas
development (From: Pan and Wright, 2011). E: embryonic day; G: gestational; W: week; P
post-natal; GSIS: glucose stimulated insulin secretion.
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(Percival and Slack 1999; Puri and Hebrok 2010). In rodents, transformation of the endoderm
sheet into a gut tube occurs by e8 and pancreatic development begins when pattern epithelium
endodermal cells are directed by transcription factors to pancreatic fate (Figure 1.5) (MooreScott, Opoka et al. 2007). At e9.5 the two epithelial buds emerge from the ventral and dorsal
surfaces of the posterior foregut endoderm (Wells and Melton 2000; Lammert, Cleaver et al.
2001; Puri and Hebrok 2010). By el0.5 the partially differentiated epithelium of the two buds
(dorsal and vertical buds) form highly branched structures. At el 1.5 the gut tube begins to
undergo its first helical movements. At e l2.5 these rudimentary buds undergo branching
morphogenesis to form a ductal tree consisting primarily of undifferentiated ductal epithelia
(Artavanis-Tsakonas, Rand et al. 1999; Kemp, Thomas et al. 2003). These changes are
considered as the first transition (Habener, Kemp et al. 2005).
During the second transition between e l3-15, buds differentiate into endocrine and
exocrine cellular and proliferate and expand. By e l 5, the dorsal and ventral pancreata rotate and
fuse to form a single pancreatic organ. At e l 6.5, the epithelium expands further largely by
proliferation of acinar cells. In addition, these exocrine acinar cells separate from the central
ducts while endocrine cells begin to cluster into islet-like structures. The islets are not fully
formed until shortly before birth on el 8-19 of late gestation where the well-defined islet
architecture is observed (the third development transition). Additional islet remodeling and
maturation is completed 2-3 weeks after birth, resulting in a mature functional pancreas.

1.6. Transcription factors that contribute to pancreatic development
There are several transcriptional factors that control the development of the pancreas at
different embryonic stages and are required in adulthood to maintain (3-cell function. The early
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antero-posterior (A-P) patterning of the endoderm during embryonic development and A-P
regionalization of the naive endoderm after gastrulation is regulated by the expression of organspecific factors which are induced by signals from surrounding tissues. Transcription factors
such as Sox2 (stomach) (Que, Okubo et al. 2007), Hhex (liver) (Keng, Yagi et al. 2000;
Martinez Barbera, Clements et al. 2000), Nkx2.1 (lung) (Minoo, Su et al. 1999), Pdxl (pancreas,
duodenum, posterior stomach, common bile duct) (Offield, Jetton et al. 1996), and the caudal
homeobox genes Cdxl and Cdx2 (intestine) (Beck, Erler et al. 1995; Minoo, Su et al. 1999;
Beck, Chawengsaksophak et al. 2003) are endodermal-region and organ-specific and therefore
differentially expressed along the A-P axis. Starting at e8, A-P patterning contributes to
endoderm differentiation, with formation of the gut tube prior to emergence of the pancreatic
bud (Wells and Melton 2000). This transformation depends on signals from the near-by lateral
plate mesoderm including fibroblast growth factors (FGFs), BMPs, activin, retinoic acid (RA)
and sonic hedgehog (Shh) (Kumar, Jordan et al. 2003; Dessimoz, Opoka et al. 2006).
Expression of the pancreatic gene Pdxl is increased during early periods of development due to
repression of endodermal protein (Shh) in the pancreas-specific endoderm by the notochord
secreted fibroblast growth factor 2 (FGF2) and activin (transforming growth factor (TGF)-(3
signaling molecule) (Hebrok, Kim et al. 1998; Hebrok, Kim et al. 2000).
It has also been demonstrated in previous studies in chickens that ectopic expression of
Shh during early development leads to a loss of Pdxl expression (and other pancreatic p-cell
markers), and as a result, the pancreatic mesenchyme is transformed into duodenal mesenchyme
(Apelqvist, Ahlgren et al. 1997; Hebrok 2003). In Pdxl knockout mice the pancreatic buds are
formed but pancreatic development is arrested at e l0.5 (Jonsson, Carlsson et al. 1994; Offield,
Jetton et al. 1996). The pancreas also fails to form in human embryos with homozygous
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Figure 1.5: Schematic diagram of pancreatic development in the mouse. At e8, the
endodermal factors: hepatonuclear factor 6 (Hnf 6), hepatonuclear factor 3(3 and notochord
factors including fibroblast growth factor 2 (FGF2) and activin, repress expression of sonic
hedgehog (SHH), thus permitting expression of Pdxl, two buds are formed at e9.5 and
subsequent branching morphogenesis is also dependent upon expression of Pdxl. The second
transition between e l2.5-15, buds differentiation into endocrine and exocrine cellular and
proliferate and expansion. After e l5, the two buds fuse to form single organ and by e l9 the
endocrine cell organized into isolated clusters that condense into the islet of Langerhans (third
transition), and cell remodeling and maturation continues for 2-3 weeks after birth. (From:
Habener et ah, 2005).
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mutations in IPF1 (insulin promoter factor 1) (Stoffers, Zinkin et al. 1997).
1.7.

The pancreatic duodenal homeobox 1 (Pdxl) master regulator of pancreatic
development

1.7.1. Characteristics o f Pdxl
Pancreatic duodenal homeobox l(Pdxl) is a transcription factor expressed by the
pancreatic epithelium at e9.0 of fetal development and it is essential for pancreatic development
(Jonsson, Carlsson et al. 1994; Offield, Jetton et al. 1996; Stoffers, Zinkin et al. 1997; Holland,
Hale et al. 2002; Schwitzgebel, Mamin et al. 2003). The position of Pdxl in humans is on
chromosome 13q 12.1 and is composed of 2 exons (Stoffel, Stein et al. 1995; Sharma, Leonard et
al. 1996; Pitchford 2007). Mouse Pdxl is located at the distal end of chromosome 5, and rat
Pdxl is located on chromosome 12 (Fiedorek and Kay 1995; Yokoi, Serikawa et al. 1997). Pdxl
protein consists of 283 amino acids. As in many transcription factors , Pdxl has separate
functional domains that contains three highly conserved sub-domains spanning amino acids 1322,32-38, and 60-73 (Figure 1.6) (Peshavaria, Henderson et al. 1997). The homeodomain is
involved in DNA binding and protein-protein interactions as a transcriptional activation
mechanism. This domain includes a nuclear localization sequence consisting of 7 amino acids
(RRMKWKK) which is conserved among the studied species (Hessabi, Ziegler et al. 1999;
Moede, Leibiger et al. 1999).

1.7.2.

Role o f Pdxl in utero
Pdxl is a vital component of the signaling and transcriptional regulatory networks that

orchestrate proliferation, outgrowth, and differentiation of the pancreas. It is the first gene
required for the earliest steps of pancreas formation, in mice and humans (Ohlsson, Karlsson et
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al. 1993; Jonsson, Carlsson et al. 1994; Offield, Jetton et al. 1996; Staffers, Ferrer et al. 1997).
Pdxl is the most important transcription factor involved in control of the endocrine cell lineage
during embryonic development. Pdxl is also known as insulin promoter factor 1(IPF1), islets
and duodenum homebox 1( IDX1), somatostatin transcriptional factor 1(STF1), glucose
sensitive P-cell-specific transcription factor ( GSF), insulin upstream factor 1 (IUF1) and
xenopus homologue (XlhBox8) (Leonard, Peers et al. 1993; Jonsson, Carlsson et al. 1994;
Miller, McGehee et al. 1994; Peshavaria, Gamer et al. 1994; Offield, Jetton et al. 1996;
Macfarlane, Smith et al. 1997; Schwitzgebel, Mamin et al. 2003; Fujitani, Fujitani et al. 2006).
Haploinsufficiency of Pdxl, (Pdxl+/-) in mice leads to glucose intolerance, increased islet
apoptosis, decreased islet mass and abnormal islet architecture, indicating that Pdxl is crucial for
normal glucose homeostasis (Ahlgren, Jonsson et al. 1998; Dutta, Bonner-Weir et al. 1998;
Brissova, Shiota et al. 2002). These findings are consistent with the report that humans
heterozygous for an inactivating mutation of Pdxl suffer from defective insulin secretion and
develop maturity-onset diabetes of the young (MODY 4) (Staffers, Stanojevic et al. 1998;
Macfarlane, McKinnon et al. 1999; Clocquet, Egan et al. 2000). In several animal experimental
models (rat, fish), deficiency of Pdxl has been shown to cause impairment in P-cell function
with age (Milewski, Duguay et al. 1998; Seufert, Weir et al. 1998; Huang, Liu et al. 2001;
Leibowitz, Ferber et al. 2001; Yee, Yusuff et al. 2001). Also in humans, mutations in IPF1 leads
to impairment of glucose responsiveness and diabetes (Staffers, Ferrer et al. 1997; Milewski,
Duguay et al. 1998; Seufert, Weir et al. 1998; Staffers, Stanojevic et al. 1998; Hani, Staffers et
al. 1999; Macfarlane, Frayling et al. 1999; Clocquet, Egan et al. 2000; Huang, Liu et al. 2001;
Leibowitz, Ferber et al. 2001; Yee, Yusuff et al. 2001).

Figure 1.6: Human Pdxl protein and gene structure. A: Human Pdxl protein structure. Nterminal region consists of 3 sub-domains, subdomain A (13-22), subdomain B (32-38),
subdomain C (60-73). In middle region Pdxl contains an antennapedia like homeodomain which
is involved in DNA binding and protein-protein interactions. This domain includes a nuclear
localization sequence consisting of 7 amino acids (RRMKWKK). B: Promoter structure and
potential transcription factor binding sites of the Pdxl gene. (From: Ashizawa et al., 2004).
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The cause of P-cell dysfunction in Pdxl deficiency has been studied in multiple systems
including both mouse models and cell lines Based on these studies, a number of mechanisms
have been explained which involve: (1) higher (3-cell apoptosis and loss of anti-apoptotic genes
(Johnson, Ahmed et al. 2003; Johnson, Bemal-Mizrachi et al. 2006); (2) inactivation of
Pdxl downstream target genes involved in insulin transcription and secretion, such as Glut2, GK,
MafA, Nkx6.1, and insulin (Ahlgren, Jonsson et al. 1998; Wang, Maechler et al. 2001; Brissova,
Shiota et al. 2002; Chakrabarti, James et al. 2002; Cissell, Zhao et al. 2003; Hagman, Hays et al.
2005; Iype, Francis et al. 2005; Zhao, Guo et al. 2005; Raum, Gerrish et al. 2006); and (3)
inability to generate new P-cells (Sharma, Zangen et al. 1999; Holland, Gonez et al. 2005).

1.7.3.

Pdxl in early pancreas development
Pdxl is expressed in rats at e8.5-e9.0 in pancreatic progenitor cells, an indication that

Pdxl expression can be used as a marker of early pancreatic development (Guz, Montminy et al.
1995; Ahlgren, Jonsson et al. 1996; Offield, Jetton et al. 1996). Pdxl is expressed in dorsal and
ventral pre-pancreatic endoderm and is maintained until later stages specifically in p-cells (Guz,
Montminy et al. 1995; Sander and German 1997). Studies in Pdxl knockout mice showed that
there is initial pancreatic bud formation but further branching is arrested (Jonsson, Carlsson et al.
1994; Guz, Montminy et al. 1995). There is also severely impaired gastrointestinal development,
including distorted gastro-duodenal junction, loss of Brunner’s glands, and defective
enteroendocrine differentiation in the stomach and duodenum (Larsson, Madsen et al. 1996;
Offield, Jetton et al. 1996; Hale, Kagami et al. 2005; Jepeal, Fujitani et al. 2005). Pdxl knockout
mice fail to develop the ventral pancreatic rudiment due to an arrest in dorsal pancreas
development after initial budding, which results in a developmentally retarded tissue (Jonsson,
Carlsson et al. 1994; Offield, Jetton et al. 1996). In addition, inactivation of Pdxl in the mouse
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leads to loss the islet cell phenotype; reduce insulin and GLUT2 expression leading to diabetes
(Ahlgren, Jonsson et al. 1998). However, it is not well understood if the ventral bud is formed
initially and then reverts to a bile duct or duodenal fate in the absence of the Pdxlgene.

1.7.4.

Pdxl during mid to late pancreas development
In addition to its pivotal role in specifying the fate of progenitor cells within the early

pancreatic buds, Pdxl also plays an important role in proliferation and differentiation. It is
essential for expansion and differentiation of acinar tissue and islets during the second transition
(Gu G, 2002). In order to assess the function of Pdxl at different time point of pancreas
development, in mouse a tetracycline- regulated system which selectively represses Pdxl at
different time points after the formation of the initial pancreatic buds was used (Slack 1995;
Holland, Hale et al. 2002). The deletion of Pdxl function at el 1.5 and el 2.5 produced a cystic
pancreas with very limited and immature acinar formation and diminished expression of the
critical acinar regulator Ptfla (Slack 1995; Holland, Hale et al. 2002). Therefore, maintenance of
low level Pdxl expression in acinar cells is required for their formation and differentiation
(Holland, Hale et al. 2002; Hale, Kagami et al. 2005). Pdxl deletion at the beginning of the
second transition at el 3.5 prevents proper differentiation of acinar cells (Hale, Kagami et al.
2005). At e l6.5, Pdxl protein is normally down regulated in acinar cells (Guz, Montminy et al.
1995); ectopic expression of Pdxl in acinar cells after the secondary transition leads to
dysmorphogenesis of cells with high rate of proliferation, apoptosis, and eventual infiltration
with fat (Heller, Stoffers et al. 2001).
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1.7.5.

Role o f Pdxl in the adult Pancreas
Pdxl expression is largely limited to P-cells in the islet and in a few 5-cells in the late

gestational and in the mature pancreas (Guz, Montminy et al. 1995). Pdxl importance is related
mainly to differentiation as well as the maintenance of the P-cell phenotype. In mature P-cells,
Pdxltransactivates insulin (Chakrabarti, James et al. 2002; Cissell, Zhao et al. 2003; Le Lay,
Matsuoka et al. 2004; Iype, Francis et al. 2005), and other genes involved in glucose sensing and
metabolism such as GLUT2 (Waeber, Thompson et al. 1996; Lottmann, Vanselow et al. 2001)
and GK (Watada, Kajimoto et al. 1996; Yamagata, Furuta et al. 1996). Deletion of Pdxl in adult
mice results in a diabetic phenotype (Holland, Gonez et al. 2005). Moreover, the progressive
loss of Pdx 1 protein levels with age might account for the increasing incidence of P-cell
dysfunction and impaired glucose tolerance (Weir, Sharma et al. 1997; Thomas, Devon et al.
2001; Brissova, Shiota et al. 2002; Weir and Bonner-Weir 2004).

1.7.6.

Pdxl cellular localization within f -cells
The localization of Pdxl in the P-cell has an important role in the regulation of gene

transcription (Ardestani, Sauter et al. 2011). Sequestration of Pdxl in the cytoplasmic
compartment is thought to serve as a mechanism to attenuate the expression-promoting effect of
the protein in the nucleus. Furthermore, it has been shown that high glucose levels will enhance
Pdxl nuclear translocation which will affect insulin gene transcription (Macfarlane, Frayling et
al. 1999) and conversely, exposure of pancreatic islets to elevated level of fatty acids will lead to
reduction in Pdxl nuclear localization (Hagman, Hays et al. 2005). Therefore, activation of
Pdxl involves a cascade of signals that include stress-activated protein kinase 2 (SAPK2) and
phosphatidylinositol 3-kinase (PI3K) (Macfarlane, Smith et al. 1997; Macfarlane, McKinnon et
al. 1999). Phosphorylation of Pdxl results in its activation and translocation to the nucleus
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where it exerts its gene expression promoting activity. It has been recently shown that glycogen
synthetase kinase 3 (GSK3) phosphorylates Pdxl on serine 61 and/or serine 66 in response to
oxidative stress which leads to degradation of Pdxl protein (Boucher, Selander et al. 2006; Liu,
Tanabe et al. 2008). However, other studies have shown that oxidative stress inhibits Pdxl
nuclear localization and DNA binding through activation of c-Jun N-terminal Kinase (JNK)
pathway (Kawamori, Kajimoto et al. 2003). Some other studies also suggested that posttranslational modification of Pdxl such as addition of ubiquitin-like protein called the ubiquitinrelated modifier 1 (SUMO-1) may play a role in its trafficking between the cytosol and the
nucleus (Kishi, Nakamura et al. 2003).

1.7.7.

Pdxl regulation o f downstream target genes
In (3-cells, Pdxl regulates a number of genes involved in maintaining (3-cell identity and

function, such as insulin (Chakrabarti, James et al. 2002; Le Lay, Matsuoka et al. 2004; Iype,
Francis et al. 2005), Glut2 (Waeber, Thompson et al. 1996; Lottmann, Vanselow et al. 2001),
GK (Watada, Kajimoto et al. 1996; Watada, Kajimoto et al. 1996) and Pdxl itself (Gerrish,
Cissell et al. 2001). Our study will focus on the genes that are involved in glucose homeostasis
(e.g. insulin, Glut2 and GK).

1.7.8.

Pdxl and insulin
Insulin is secreted by the (3-cells and regulates carbohydrate and fat metabolism. Glucose

homeostasis requires a very tight regulation of insulin synthesis and secretion. Insulin is
synthesized in (3-cells via a complex process that starts with transcription of the proinsulin gene
to messenger RNA (mRNA), stimulated by glucose in both human and rodent (Skoglund,
Hussain et al. 2000). Pro-insulin is synthesized in the ER, transported through the Golgi and
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sorted into immature secretory granules. Proinsulin is then processed to mature insulin and
stored in large dense core vesicles (LDCVs) (Eliasson, Abdulkader et al. 2008).
In rodents, insulin is coded by 2 non-allelic insulin genes called insulin 1 and insulin 2
(Wentworth, Schaefer et al. 1986; Duvillie, Currie et al. 2002). The human insulin gene is
located on chromosome 11 pi 5.5 and contains 3 exons and 2 introns (Harper, Ullrich et al. 1981).
In P-cells, the activation of insulin gene transcription depends on multiple nuclear factors that
interact with each other and with sequences on the insulin gene promoter to build a
transcriptional activation complex (Melloul, Marshak et al. 2002). There are several
transcriptional factors that have been shown to bind the promoter regions of insulin gene (Figure
1.7) .
Pdxl has an important role in insulin gene transcription. It interacts with other proteins at
the insulin promoter such as p2/Neuro D l, E47/Panl, p300 coactivator and Bridge-1 (Figure
1.7) (Thomas, Yao et al. 1999; Ohneda, Mirmira et al. 2000; Qiu, Guo et al. 2002; Ashizawa,
v
Brunicardi et al. 2004). Previous studies suggested that one mechanism through which Pdxl
promotes insulin gene transcription is the induction of histone modifications at the insulin
promoter. At high levels of glucose, Pdxl has been reported to recruit the histone
acetyltransferase (HAT) p300 to the insulin promoter leading to increased acetylation of histone
H4 and consequently increased insulin gene expression (Qiu, Guo et al. 2002; Mosley, Corbett et
al. 2004; Mosley and Ozcan 2004). Pdxl has also been shown to recruit histone
methyltransferase Set9 to the insulin promoter leading to déméthylation of histone H3 Lys4
(Francis, Chakrabarti et al. 2005). Both histone acetylation and méthylation lead to changes in
the chromatin structure that promotes insulin gene transcription (Francis et al. 2005)
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Figure 4-7: Schematic representation of the human and rat insulin gene promoters.
Potential transcription factor binding sites are indicated by boxes. Human insulin
promoter (A); Rats carry 2 non allelic insulin genes: Rat insulin promoter I (B), Rat
insulin promoter II (C). In rats the A4 and A3 elements bind to Pdxl and other
homeodomain-containing proteins. (Modified from: Ashizawa S., 2004).
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(Francis, Chakrabarti et al. 2005; Francis, Babu et al. 2006). Moreover, it has been shown
that Pdxl regulates insulin gene transcription by promoting a transcriptionally active
chromatin structure, which enhances elongation by polymerase II (Francis, Chakrabarti et
al. 2005; Iype, Francis et al. 2005). In addition to this, there is evidence that Pdxl recruits
histone deacetylase (HDAC) to the insulin promoter in response to low glucose levels to
down-regulate insulin gene transcription (Mosley and Ozcan 2004).

1.7.9.

GL UT2 and glucose transport to p-cells
Glucose is transported into P-cells in rodents by the glucose transporters (De Vos,

Heimberg et al. 1995; Richardson, Hussain et al. 2007). Glucose transporter 2 (GLUT2)
is a member of the SLC2A gene family; it is a transmembrane carrier protein that enables
glucose to be carried across the cell membrane. It is expressed in the liver, small
intestine, kidney, restricted areas of the brain, and the pancreatic p-cells (Thorens, Sarkar
et al. 1988; Arluison, Quignon et al. 2004; Arluison, Quignon et al. 2004). Figure 1.8
shows the transcription factors that regulate GLUT2 gene expression in different species
(Bae, Kim et al. 2010).
During pancreas development, GLUT2 is expressed in the definitive endoderm
before pancreatic bud formation and before the appearance of the insulin-secreting Pcells. In P-cells, GLUT2 expression is reduced in animal models of diabetes (Joms and
Klempnauer 1995; Joms, Tiedge et al. 1996; Bonny, Roduit et al. 1997). However, no
decrease in GLUT2 abundance has been reported in the liver or kidney of these animals,
which suggests that expression of the GLUT2 gene is under the control of different
factors in pancreatic P-cells compared with other GLUT2-expressing tissues (Thorens,
Wu et al. 1992).
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Figure 1.8: Schematic of transcriptional regulatory elements on the GLUT2gene
promoters. Abbreviations: HNF1 A, HNF1 homeobox A; EP300, El A binding protein
p300; FOXA2, forkhead box A2 (also known as HNF3B); PDX1, pancreatic and
duodenal homeobox 1; SP1, Spl transcription factor; PAX6, paired box 6; MXD1, MAX
dimerization protein 1; EGR1, early growth response 1; MAFA, v-maf
musculoaponeurotic fibrosarcoma oncogene homolog A; NEUROD1, neurogenic
differentiation 1; PPARA, peroxisome proliferator-activated receptor alpha; PPARG,
peroxisome proliferator-activated receptor gamma; FOXOl, forkhead box 01; RXRA,
retinoic X receptor alpha; 0NECUT1, one cut homeobox 1 (also known as HNF6);
NR4A1, nuclear receptor subfamily 4, group A, member 1; SREBFlc, sterol regulatory
element binding transcription factor lc; CEBPA, CCAAT/enhancer binding protein
(C/EBP) alpha; CEBPB, CCAAT/enhancer binding protein (C/EBP) beta; HRE, HNF
response element; PPRE, PPAR response element; NBRE, nerve growth factor I-B
response element; SRE, SREBF response element; C/EBPRE, CEBP response element.
+1, transcription start site. (Reproduced from Bae et al., 2010).
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In (3-cells, the GLUT2 promoter is controlled by the Pdxl homeobox factor
through the consensus Pdxl binding TAAT motif (Waeber, Thompson et al. 1996).
Increase in ATP levels as a result of glucose metabolism is the initial step in glucosestimulated insulin secretion (GSIS) (Prentki and Matschinsky 1987; Deeney, Prentki et
al. 2000; Kowluru 2008). Glucose is then phosphorylated by glucokinase (GK) to glucose
-6- phosphate (G-6-P). In this context GLUT2 functions as a membrane receptor of
glucose. Independently of glucose metabolism, GLUT2 detects the presence of
extracellular glucose and transduces a signal to modulate cell functions such as (3-cell
insulin secretion, renal reabsorption, and intestinal absorption in response to the glucose
environment. Zucker diabetic rats have reduced expression of islet GLUT2 leading to
loss of GSIS. These animals are obese and develop T2DM between postnatal weeks 7-9
(Johnson JH, 1990). Mice fed with high fat diet or treated with glucocorticoids have
decreased Pdxl and GLUT2 protein levels and loss of GSIS (Kim, Iwashita et al. 1995;
Reimer and Ahren 2002). Moreover, GLUT2 sugar detection deficient (SDD) mice have
a phenotype with urinary glucose loss, low insulin secretion, and increased number of
small islets, suggesting that GLUT2 receptors are involved in islet formation and function
(Stolarczyk, Le Gall et al. 2007). Also, in humans the loss of GLUT2 expression in P*
cells is associated with hyperglycaemia and impaired GSIS (Ohtsubo, Takamatsu et al.
2005).

1.7.10.

Glucokinase (GK)

The GK gene is located in chromosome 7pl 5.3-pl5.1, and consists of 12 exons
that span 45,168 bp that encodes a 465 amino acid protein (Jetton, Liang et al. 1994).
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Figure 1.9: Schematic representation of transcriptional regulatory elements in the
pancreatic GK gene promoter. Abbreviations: PDX1, pancreatic and duodenal

\
homeobox 1; SP1, Spl transcription factor; FOXOl, forkhead box 01; NEUR0D1,
neurogenic differentiation 1; E47, an immunoglobulin enhancer-binding factor; EP300,
E1A binding protein p300; NR0B2, nuclear receptor subfamily 0, group B, member 2
(also known as SHP); PPARG, peroxisome proliferator-activated receptor gamma;
RXRA, retinoic X receptor alpha; UPE, upstream promoter element; FRE, FOXOl
response element; PPRE, PPAR response element. (Reproduced from Bae et al., 2010).
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Although GK is expressed in most tissues including the pancreas, liver, brain and
endocrine cells of the gut, the highest expression levels are found in the pancreatic P-cells
(Jetton, Liang et al. 1994; Schuit, Huypens et al. 2001). GK plays an essential role in
blood glucose homeostasis acting as a glucose sensor in P-cells by controlling the rates of
entry of glucose into the glycolytic pathway and its subsequent metabolism to glucose-6phosphate (G-6-P) (Meglasson and Matschinsky 1984). G-6-P then enters the glycolytic
pathway to generate ATP. The increased ATP/ADP ratio promotes ATP-dependent K+
channel closure and membrane depolarization resulting in opening of voltage-dependent
Ca

channels, causing a surge in intracellular free calcium, thus facilitating exocytosis

of insulin granules and release of insulin to the extracellular space (Barg 2003). Specific
p-cell GK knockout has been shown to result in death by postnatal day 4 due to severe
hyperglycemia (Bali, Svetlanov et al. 1995; Grupe, Hultgren et al. 1995). Global
homozygous GK knockout mice demonstrate prenatal lethality due to severe diabetes
(Grupe, Hultgren et al. 1995; Postic, Shiota et al. 1999). On other hand, global
heterozygous GK knockout mice develop early mild onset diabetes which mimics the
MODY2 phenotype (Grupe, Hultgren et al. 1995; Postic, Shiota et al. 1999) while P-cell
specific heterozygous GK knockout results in mild diabetes with decreased insulin
secretory response (Terauchi, Sakura et al. 1995; Postic, Shiota et al. 1999). Furthermore,
GK haploinsufficient mice demonstrate impaired GSIS and decrease P cell replication in
response to high fat diet (Terauchi, Takamoto et al. 2007) and the use of glucokinase
activators (GKAs) treatment leads to improvements in GSIS in these mice (Gorman,
Hope et al. 2008).
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The GK gene is regulated by various transcriptional factors (Figure 1.9). Leibiger
and his group have shown that glucose-induced upregulation of GK gene expression is
mediated by insulin (Leibiger, Leibiger et al. 2001). On other hand, recent studies have
shown that the role of glucose or insulin in the activation of GK occurs by stabilizing
rather than up-regulating of GK in insulinoma cells. Furthermore, Pdxl activates the
promoter of the GK gene in pancreatic cells at the upstream prompter element 3 UPE3
motif (Figure 1.9). However, (3-cell specific disruption of Pdxl did not affect the
expression of the GK gene (Ahlgren, Jonsson et al. 1998).

1.8. Rationale
Pdxl regulates pancreatic development, and p-cell differentiation and function by
controlling the fate of progenitor cells within the early pancreatic buds (Stoffers, Ferrer et
al. 1997; Kojima, Fujimiya et al. 2003; Sapir, Shtemhall et al. 2005; Zhao, Guo et al.
2005). It also plays a distinct role in the proliferation of differentiating cells, and
maintenance of selected cell types. In adulthood, Pdxl is vital for transcriptional
regulation of the insulin and somatostatin genes and other specific genes including Glut2,
GK and islet amyloid polypeptide. Mutations in the Pdxl gene may contribute to the
development of T2DM in humans, as heterozygote of such mutations have been linked
to a high frequency of early-onset type 2 diabetes development, designated as maturityonset diabetes of the young 4 (MODY4). In addition, Pdxl-mi\\ mice demonstrate
pancreatic agenesis (Jonsson, Carlsson et al. 1994; Ahlgren, Jonsson et al. 1996; Offield,
Jetton et al. 1996).
Studies in our lab have showed that there is a relationship between maternal
dietary restriction (LP diet) during pregnancy and adult life disease (e.g., T2DM).
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Therefore, this model can be used to investigate the dynamic sequence of events that are
involved in the pathophysiology of T2DM as a result of early pregnancy. As Pdxl plays
crucial roles in islet development, growth and function, and impairment of Pdxl
expression is associated with impaired insulin biosynthesis and secretion, we predict that
LP model causes diabetes in adult life due to alterations in Pdxl and its downstream
target genes.
This work is an attempt to uncover some aspects of the developmental
predisposition to adulthood diseases such as DM. Further understanding of the molecular
basis of fetal programming during pregnancy could provide a unique and novel
opportunity to suggest measures that may prevent the development of diabetes in adult
life.

1.9. Hypothesis and objectives
I hypothesize that low protein diet (LP) during early stages of development
will lead to the development of T2DM in adulthood by decreasing p-cell function.
Specifically, LP will lead to alterations in Pdxl gene expression, resulting in the altered
expression of downstream target genes that will lead to the development of T2DM.
Objective
The objectives of this research project were:
1. To explore the molecular mechanism(s) that link environmental insult during
gestation to development of chronic diseases later in life using the low protein
(LP) diet rat model.
2. To identify at different time points (at d21 and dl30) any alterations in the
overall expression of pancreatic Pdxl gene and protein in offspring of rats
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treated with 20% protein (C) or 8% protein (LP) diet during different windows
of development.
3. To determine the overall expression of pancreatic Pdxl downstream target
genes and proteins (i.e. Insulin, GLUT2, and GK) at the same time points and
how this will affect the onset of T2DM.
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Chapter 2: MATERIALS AND METHODS

2.1. Animal procedures
Virgin female Wistar rats were purchased at breeding age weighing 250-300g
from Charles River Laboratories (Montreal, QC, Canada) and were bred in our facilities
at Lawson Health Research Institute (London, ON, Canada). The animals were housed
individually and maintained in a temperature- controlled room at 22°C on a 12:12 hour
light-dark cycle with food and water available ad libitum. Nulliparous females were
cycled and mated with male rats on the night of pro-estrous. Pregnancy was confirmed by
the presence of a vaginal plug and/or sperm the next morning and this was noted as day 1
of pregnancy. Immediately, dams were allocated at random to one of four experimental
conditions according to the amount of protein in the diet at windows of development
(Figure 2.1). The control diet (C) contained a 20% (w/w) protein and the low protein diet
(LP) only contained an 8% (w/w) protein. Group 1 had the (C) animals which were fed
with C diet during pregnancy, lactation and after weaning to adult day 130 (All life).
Group 2, low protein diet 1 (LP1), received LP diet all life. Group 3, low protein diet 2
(LP2), were given LP diet during gestation and lactation and C diet after weaning.
Finally, group 4, low protein diet 3 (LP3), received LP diet during gestation only, and C
diet thereafter. Offspring of all groups were followed to 130 days of age. All procedures
were performed with the approval of the Animal Care Committee of the University of
Western Ontario in accordance with guidelines given by the Canadian Council for
Animal Care (Appendix 1).
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Figure 2.1: Experimental design. Animals received two different diets: Control diet (C)
which contained 20% (w/w) protein; Low protein diet (LP) which contained 8% (w/w)
protein. Animals were divided into four groups: C group were fed with C diet all life,
LP1 group were fed with LP diet all life, LP2 group were fed with LP diet during
gestation and lactation and C diet after weaning and LP3 group were fed with LP diet
during gestation only, and C diet thereafter. Until birth, all LP groups received the same
diet; therefore, these groups were pooled together in one group (LP). At d21, LP1 and
LP2 groups received the same diet; therefore, they were pooled in one group (LP1,2) at
this time of age.
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Diets were purchased from Bio-Serv (Frenchtown, NJ, USA) and were isocaloric,
where the reduction in protein in the LP diet was balanced by the addition of
carbohydrates. Protein restriction was achieved by reduction in casein content (Table
2.1). Litters were reduced by decapitation on postnatal day 1 to 8 pups, with 4 of each
gender, to ensure uniform neonatal growth. Gender was determined by anatomical
differences; in the neonatal rat the male has a greater genital distance and larger genital
papillae. Each experimental group was composed of 6 to 8 mothers. At d21 and dl30,
one male and one female from each litter were sacrificed. Pups were weighed at day 1,21
and 130.
All in v itro studies were conducted using pancreatic tissue from d21 and dl30
animals. Twenty one day old animals were first weighed, then anaesthetized by
intraperitoneal (I.P) injection of 150mg/kg of body weight diluted ketamine/xylazine
cocktail (53% Ketamine Hydrocloride) (Sandoz Canada Inc., Quebec, QC, Canada), 7%
Rompun Xylazine (Bayer Inc. Toronto, ON, Canada) and 40% sterile distilled water.
The anaesthetic cocktail for dl30 animals was more concentrated containing 80%
ketamine and 20% xylazine (100 mg/kg). After isolation, the pancreata was weighed,
fixed in 10% formalin, or snap-frozen in liquid nitrogen or in RNAla te r then stored at 80°C until further use.

2.2. Quantitative Real Time Polymerase Chain Reaction (q R T -P C R
Following pancreas dissection, approximately half of the pancreatic tissue from at
least eight animals of each group was stored in RNA/oier (Ambion Inc., TX, USA)
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Table 2.1. Diet compositions used for C and LP groups in g/kg. Purchased from BioServ, Frenchtown, NJ, USA.
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Control (C, g/Kg)

Low Protein (LP, g/Kg)

(20% Casein)

(8% Casein)

Casein

220

90

Sucrose

213

243

Cellulose fibre

50

50

Cornstarch

80

80

Vitamin mix

2.5

2.5

Mineral mix

47

48

Soya oil

43

43

DL- Methionine

2

0.8

Chlorine chloride

4

40

Diet component
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at -80°C until RNA extraction. Given that pancreatic tissue is easily degradable, samples
were presented in RNAla te r instead of snap-freezing in liquid nitrogen which was found
to result in increased RNA degradation (Appendix 2). For total RNA extraction, the
tissue samples were removed from RNAla te r

*
t
\m

using forceps, and 30 mg of tissue was

weighed, Qiagen RNeasy Plus MINI kit were used (Qiagen Inc., Mississauga, ON,
Canada) according to the manufacturer’s specifications. The tissue samples were
removed from RNAla te r and 30mg of tissue was weighed followed by addition of 600pL
of RLT Plus Buffer (with 1% P-mercaptoethanol (p-ME) and homogenized for 30 s twice
using Polytron homogenizer (Polytron, Kinematica, Switzerland). The sample was then
centrifuged for 3 min at maximum speed in a bench-top micro centrifuge and the
supernatant was transferred to a genomic deoxyribonucleic acid (gDNA) eliminator
column and centrifuged for 30 s at 8000 x g in order to purify RNA molecules that are
longer than 200 nucleotides. Ethanol (70%) was added to the flow-through in order to
elute the lysate and precipitate the RNA. Samples were then added to an RNeasy spin

V

column and centrifuged for 15 s at 8000 x g to separate RNA from other components.
The flow through was discarded and the remaining RNA in the column was washed with
7 0 0 ¡jlL

of supplied RW1 buffer and centrifuged again for 15 seconds at 8000 x g.

To dry the RNA preparation, 500pL of RPE buffer was added to the RNeasy spin
column and centrifuged for 15 seconds at 8000 g. This step was repeated and the column
was centrifuged for 2 min, in the second wash followed by another centrifugation with a
clean collection tube at full speed for 1 min. To elute the RNA from the column, the spin
column was transferred to a new collection tube and 50pL of RNase-free water was
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placed directly on the membrane of the column and centrifuged for 1 min full speed. The
eluted solution contained the RNA and was stored at -80°C.
The quality of RNA was confirmed by analyzing the samples at London Regional
Genomics Center (LRGC). Samples with good quality RNA should show two peaks with
minimal area under the curve. RNA Integrity Number (RIN) was given on a scale of 1-10
with 1 being poor and 10 being excellent quality. RNA with less than 7 RIN was
discarded and not used for further studies (Appendix 2). Also, quality of RNA samples
was confirmed on a 2% Agarose TAE gel. Bands stained with Ethidium bromide were
visualized using an ultra violet (UV) light in Syngene Chemi Genius Bioimaging System
(Syngene, Frederick, MD, USA). Samples that displayed intact RNA were indicated by
two distinct bands at the 18S and 28S mark (Appendix 2). Also the quantity and quality
of samples were measured by spectrophotometry (Eppendorf, Bio-photometer). Samples
were considered acceptable with an absorbance ratio for the 260/280 value of 1.7-2.
RNA was reverse transcribed into first strand complimentary DISfA (cDNA) using
a Superscript III Reverse Transcriptase (Invitrogen, Carlsbad, California, USA), designed
to be used with very low and very high amounts of input RNA. The Superscript III
Reverse Transcriptase had the advantage of giving equal output of cDNA and it is able to
detect templates from as little as 1.0 pg of total RNA.

Initially, 4 pg of the RNA sample were measured and DEPC-treated water was
added. The RNA samples were then treated with DNase I, Amplification Grade
(Invitrogen, Carlsbad, California, USA). DNase I, Amp Grade (lU/pL) and 10X DNase I
reaction buffer were added to the measured 4 pg of RNA, and incubated for 15 minutes at

53

room temperature. Subsequently 25 mM EDTA was added and the mixture was
incubated at 65°C for 10 minutes to inactivate the DNase I enzyme. Random Hexamers
(50 ng/pL) were added to the samples, incubated for 10 minutes at 65°C and then
immediately placed on ice for 5 minutes.
A master mix containing 10X RT buffer, 25 mM magnesium chloride (MgCU),
0.1M DTT, lOmM deoxyribonucleotide triphosphates mix (dNTPs: dATP, dCTP, dGTP
and dTTP) (Invitrogen 10297-018, Carlsbad, CA, USA), RNase Out Recombinant RNase
Inhibitor and Superscript III Reverse Transcriptase (200 U/pl) was used. Total master
mix was added to each DNase I-treated RNA sample, placed in the Thermocycler with
the following program: 25°C for 10 minutes, 50 °C for 50 minutes, followed by 85°C for
5 minutes to terminate the reaction. cDNA samples were then stored at -20°C until further
use.
Real time quantitative Polymerase Chain Reaction (qRT-PCR) was performed
using SYBR® Green Supermix (Bio-Rad Laboratories, Hercules, CA, ÜSA) in a Bio-Rad
C l000 Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA) sequence detection
system. Primers sequences purchased from Invitrogen (Invitrogen, Carlsbad, CA, USA,
table 2.2). Pdxl and housekeeping ß-Actin primer sequences were designed according to
Hagman, et al., and insulin primers which were designed in our lab (Hagman, Hays et al.
2005).
The efficiency of the primers was assessed using a serial dilution of samples
ranging from 1:4, 1:16, 1:64, 1:256, 1:1024 and a blank (zero of cDNA). The log of input
cDNA was plotted against the comparative threshold (CT) value and primer pairs with a
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slope of approximately -3.4 and efficiency around 100 was then used for qRT-PCR
studies.
Quantitative RT-PCR was carried out by preparing a master mix for each primer
set with 0.6pL of 2.5pM primer mix of interest, 0.4pL of ultrapure distilled
DNAse/RNase-ffee water (Gibco/Invitrogen, Burlington, ON, Canada), and 6.0 pL of
iQ™ SYBR® Green Supermix (BioRad Laboratories 170-884, Hercules, CA, USA) per
well. Five pL cDNA diluted 1:10 was loaded in triplicate into Hard-Shell® 384-well
Thin-Wall PCR plates (black shell, white well; Bio-Rad Laboratories, Hercules, CA,
USA) and then 7pL of master mix was added to each well.
The plate was centrifuged for 2 minutes at 300xg. Subsequently, the plate was
read in Bio-Rad C l000 Thermal Cycler (Bio-Rad C l000 Thermal Cycler, CFX 384,
Real-Time System, Hercules, CA, USA) on the following protocol: Step one 50°C for 2
minutes, step two 95°C for 10 minutes, step three 95°C for 15 seconds, and step four 60°C
for 1 minute. Data was automatically computed using CFX Manager Software (Bio-Rad
Laboratories, Hercules, CA, USA).
Mean Ct values of gene interest were calculated from triplicate measurements and
then compared with control (p-Actin) (ACt= Ct target - Ct P-Actin).

Values

were

substracted from the d21 control groups (AACt= ACt target- ACt d21 control). Calculate
fold change using the formula 2'AACt.

Since SYBR Green does not differentiate between different DNA strands,
assessing melting points was an important quality control check. All products were
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monitored for their melting point following the Real Time PCR amplification and a melt
curve was established: temperature is raised by a fraction of a degree and the change in
fluorescence is measured. At the melting point, the two strands of DNA separate and
fluorescence rapidly declines. The CFX Manager (Bio-RAD Laboratories, Hercules, CA,
USA) software plots the rate of change of relative fluorescence units with time on the yaxis versus the temperature on the x-axis. The melting temperature (Tm) is the peak.
Samples with multiple peaks were discarded.

2.3. Western blot
Fifty mg samples from frozen pancreata were placed in lmL lysis buffer (50 mM
Tris HCL (tri hydroxymethyl aminomethane) pH 7.4, 150mM sodium chloride, ImM
phenylmethanesulfonylfluoride (PMSF), 0.1% Igepal (MP Biomedical, Solo, OH, USA),
0.1 % Trasylol, Complete Mini tablet (Roche Diagnostics, Indianopolis, IN, USA).
Samples were homogenized (IKA, T10 Basic SI Disperser) then spun at 13000xg at 4°C
for 30 minutes. Supernatants were removed to new tubes and then quantified and stored
at -80°C until later use.
Protein concentration was determined using a MICRO BCA™ Protein Assay
Reagent Kit (Thermo Scientific Pierce Protein Research Products 23235, Rockford, IL,
USA). Samples were loaded in 2 wells at 1:100 dilutions. In each well lOOpL of diluted
sample was loaded. Then 100 pL of Working Reagent solution (5mL MA: 4.8mL MB:
200pL MC) were added to each well and incubated at 37°C for 30 minutes. After
allowing the plate to cool to room temperature, absorbance was measured at 575 nm
using a microplate reader (BioRad, Laboratories, Hercules, CA, USA). The protein
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Table 2.2: Sequences of primers used in qRT-PCR.
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Gene of
interest

Forward primer (5’-3’)

Reverse primer (5’-3’)

Pdxl

CCGCGTTCATCTCCCTTTC

TGCCCACTGGCTTTTCCA

Insulin I

CCCGGCAGAAGCGTGGCATT

CATTGCAGAGGGGTGGGCGG

GLUT2

GTCCAGAAAGCCCCAGATACC TGCCCCTTAGTCTTTTCAAGCT

ß-Actin

ACGAGGCCCAGAGCAAGA,

TTGGTTACAATGCCGTGTTCA
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concentrations were determined by comparing to a bovine serum albumin (BSA) standard
curve. The assay sensitivity ranged from 20 to 2000pg/ml.

Twelve percent polyacrylamide separating gels were prepared by combining 2.5
ml. of 1.5 M Tris (EMD Chemicals, Mississauga, ON, Canada), pH 8.8, 200 pL of 10%
Sodium dodecyl sulfate (SDS), 4 mL of 30% Proto Gel™ acrylamide (National
Diagnostics, Atlanta, GA, USA), 2.63 mL of water, 665 pL of 1.5% ammonium
persulfate (APS), and 5 pL of TEMED. After 45 minutes of polymerization, the stacking
gel was prepared by combining 893pL of 30% acrylamide, 2.94 mL water, 630 pL of 1M
Tris, pH 6.8, 200 pL of 10% SDS, 332 pL of 1.5% APS, and 8 pL of TEMED. Stacking
gel was poured and set on top with 15 well comb inserted. Also, 16% of polyacrylamide
separating gels were used for separation of low Molecular weight (MW) protein, were
prepared same as 12% except the amount of 30% acrylamide were used 5.33 ml with 1.3
mL water.

V
Samples were combined with 5X loading buffer (1M Tris, pH 6.8 (EMD Chemicals,
Mississauga, ON, Canada), 10% glycerol, 2% SDS, 0.02% (3-ME, 0.0001% Bromophenol
Blue) to make a total volume of 50 pL per sample and the mixtures were boiled for 5
minutes at 95 °C. Samples from three to five animals per treatment (C, LP1, LP2, LP3),
age ( d21, dl30), and gender (male, female) were loaded (50pg of protein 20 pL) and
then separated by running in Laemmli electrophoresis buffer (0.03% Tris Base (EMD
Chemicals, Mississauga, ON, Canada), 0.14% Glycine, 0.01% SDS) for approximately
45 minute to 1.5 hours at 130 V. The gel was then removed and stacked in Invitrogen
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iBlot machine (Invitrogen, Carlsbad, CA, USA) for a seven-minute semi-dry transfer
onto nitrocellulose membrane (Invitrogen, Carlsbad, CA, USA).
After transferring, membranes were stained with Ponceau Red S solution (0.1%
Ponceau S, 5% acetic acid) for 1-2 minutes to visualize protein quality and ensure proper
transfer. Ponceau S was washed off completely followed by blocking in 5% non-fat dry
milk in Tris-Buffered Saline Tween 20 (TBS-T) 0.024% Tris Base (EMD Chemicals,
Mississauga, ON, Canada), 0.08% sodium chloride, 0.05% Tween 20 (Sigma-Aldrich
P1379, St. Louis, MO, USA) for 60 minutes at room temperature. The membranes were
initially probed for (3-Actin (the internal loading control) using primary antibody raised
against rat (1-Actin (Abeam, Cambridge, MA, USA) that was diluted 1:5000 in blocking
buffer and the membranes were incubated overnight at 4°C while rocking. They were
then washed with TBS-T and the secondary antibody diluted in blocking buffer (1:10000,
a-rabbit-IgG-HRP (Santa Cruz Biotechnology sc-2004, Santa Cruz, CA, USA)) was
added and incubated for 60 minutes at room temperature. The membranes were washed
again in TBS-T and then TBS before addition of picoLUCENT™ PLUS (G-Biosciences
786-02, A Geno Technology Inc., Maryland Heights, MO, USA) for chemiluminescent
reaction.

The blots were incubated for 5 minutes in picoLUCENT™ PLUS before

visualization with SYNGENE

ChemiGenius2 Bioimaging System (SYNGENE,

Frederick, MD, USA) with Digital CCD Camera (Hamamatsu Photonics Systems C474280-12AG, Bridgewater, NJ, USA). Images were taken in a series of 30s, lmin, 3min, and
5min exposure times and then edited with GeneSnap (SYNGENE, Frederick, MD, USA)
software to select for appropriate lighting and exposure time.
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Nitrocellulose membranes were stripped by incubating for 30 minutes in stripping
buffer (lOOmM ß-ME, 2% SDS, 62.5mM Tris-HCl, pH 6.7 in water) at 55°C.
Membranes were washed briefly once in TBS-T then for 7 minutes in TBS-T and the
procedure was repeated for the protein of interest, rabbit anti-Pdxl antibody (generous
gift from Dr. Chris Wright (Vanderbilt University, Nashville, TN, USA) was diluted at
1:1000. Membranes were then incubated with a-rabbit-IgG-HRP secondary antibody
((1:1000) (Santa Cruz Biotechnology sc-2004, Santa Cruz, CA, USA) and visualized, as
described above. The same steps were used for the other proteins with some
modification. For insulin, the running time of the gel was set for about 30 minutes. Also,
16 % polyacrylamide separating gels were used. Membranes were probed with a rabbit
anti-insulin antibody (1:200) (Santa Cruz Biotechnology, sc-9168, Santa Cruz, CA, USA)
with goat anti rabbit secondary antibody (1:10.000) (Santa Cruz Biotechnology, sc-2004,
Santa Cruz, CA, USA).
Twelve percent polyacrylamide separating gels were used for separation GK and
GLUT2 proteins and steps were same as above. Goat anti-GLUT2 antibody (1:200) Santa
Cruz Biotechnology, sc-7580, Santa Cruz, CA, USA) was used with secondary anti-goat
IgG-HRP (Santa Cruz Biotechnology sc-2020, Santa Cruz, CA, USA). Also, to detect
GK a rabbit anti-GK antibody (1:200) (Santa Cruz Biotechnology sc-2020, Santa Cruz,
CA, USA) was used with secondary goat anti-rabbit IgG-HRP (1:10.000),(Santa Cruz
Biotechnology, sc-2004, Santa Cruz, CA, USA). After the nitrocellulose membranes
were stripped by incubating for 30 minutes in stripping buffer. The membranes were
probed with rabbit anti-ß-Actin antibodies (Abeam ab8227, Cambridge, MA, USA),
which were used as loading control, followed by the same steps as above.
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Images were analyzed using Gene Tools (Syngene, Frederick, MD, USA) where
individual bands were selected and intensity was calculated by the computer software
based on the total number of pixels occupied.

2.4. Separation of cytoplasmic and nuclear fractions
Cytoplasmic and nuclear compartments were separated as previously described
(Kawamori, Kajimoto et al. 2003; Hagman, Hays et al. 2005). Briefly, a piece from snapfrozen pancreatic tissue was placed into ice cold 250 pL NE1 (10 mM HEPES pH 7.9, 10
mM MgCh, 5 mM KC1,1% Triton X, 0.1 mM EDTA, ImM DTT, supplemented with
mini-protease inhibitor (Roche Diagnostics, Indianopolis, IN, USA). Samples were
homogenized for 30 s using a PolyTron PT 2100 (Kinematica AG. Switzerland) then
incubated on ice for 15 min. Homogenates were then centrifuged at 12000 rpm for 10
min at 4 °C and supernatants were saved as they had the cytoplasm fraction in a freshlabeled tube placed on ice. Pellets were then re-suspended in ice cold lOOOpL NE1 and
vortexed briefly, then centrifuged at 5000 rpm for 5 minutes at 4 °C. The supernatant
were aspirated off while adding 250 pL of NE2 (25% glycerol, 20mM HEPES pH 7.9,
1.5 mM MgCb, 500 mM NaCl, 0.2 mM EDTA, supplemented with a mini- protease
inhibitor tablet (Roche Diagnostics, Indianopolis, IN, USA) to pellet. The resuspended
pellet was incubated on ice for 1 hour and vortexed every 5 minutes then spun at 13000
rpm for 20 minutes. Supernatant were removed to new tube and then quantified and
stored at -80°C until later use. Protein concentration was determined using a MICRO
BCA™ Protein Assay Reagent Kit involving same steps as above. Gel electrophoresis
and immunoblotting were conducted as described, using rabbit anti-histone H3 antibody
(1: 1000) (MILLIPORE 06-755, Billerica, USA) for the nuclear fraction as internal
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loading control a mouse anti p-tubulin monoclonal antibody ( 1:1000) (MILLIPORE OS661, Billerica, USA) was used as a internal loading control for cytoplasmic fraction.

2.5. Immunohistochemistry (IH C )
2 .5 .1 .

Tissue fixation and sectioning
After 24 hours fixation of pancreatic tissue in 10% neutral buffered formalin

(West Chester, PA, US), pancreata were dehydrated and embedded in paraffin
(University Hospital Pathology Lab, London, ON, CA). Serial sections of the pancreas
were cut (5 pm) with a Leica Rotary Microtome (Leica Microsystems, Richmond Hill,
ON, Canada) and mounted on SuperFrost®- Plus glass slides (Fischer Scientific, Toronto,
ON, Canada) and incubated at 50°C for 24 hours.

2 .5 .2 .

Localization o f glucagon and insulin by immunohistochemistry
Dual immunolocalization was performed on sections to localize insulin and

glucagon. Sections from pancreata isolated from at least three animals per treatment
group (male C, male LP3) at dl30 were deparaffinized in xylene, rehydrated in
descending ethanol series, washed in Phosphate Buffered Saline (PBS) and then
subsequently incubated for 15 min in 3% hydrogen peroxide to inhibit endogenous
peroxidase activity. After rinsing with tap water, sections were counterstained with
Carazzi’s Hematoxylin for 2 min at room temperature and rinsed with water and followed
by 3 washes with PBS for 3 min each. Tissues were incubated in blocking buffer (5%
horse serum and 2% Bovine Serum Albumin (BSA) in PBS for 30 min at room
temperature. All slides were then incubated with the primary antibodies; mouse anti
glucagon antibody (Sigma-Aldrich G2654, St. Louis, MO, USA) diluted 1:200 in
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antibody diluting solution (ADS) for 1 hour at room temperature in a humidity chamber.
The slides were washed in PBS and the corresponding secondary antibody, a biotinylated
horse anti-mouse IgG (1:30, Vector BA-2000, Burlington, ON, Canada) were diluted in
ADS, and 200 pL were added to the slides and incubated for 30 min at room temperature.
After washing in PBS, slides were incubated at room temperature for 30 min with the
linker Extravidin (1:30 in PBS, Sigma-Aldrich 11704758, St. Louis, MO, USA), and then
with Diaminobenzidine (DAB) (chromogen (BioGenex, San Ramon, CA, USA), as per
manufacturer’s instructions Subsequently, sections were stained for insulin on the same
slides as follows: slides were blocked with 5% normal goat serum for 30 min at room
temperature, then incubated with a rabbit anti-insulin (1:200 in ADS, Santa Cruz, sc9168, Santa Cruz CA. USA) overnight at 4°C. On the second day a biotinylated goat
anti- rabbit IgG (1:30) ( Vector BA-1000, Burlington, ON, Canada) was used diluted in
ADS and incubated for 30 min at room temperature followed by Vectastain ABCAlkaline Phosphatase (Vector Laboratories, Burlington, ON, Canada).

Insulin

localization was visualized with using Vector Red Alkaline Phosphatase Substrate Kit III
(Vector Laboratories SK 5300, Burlington, ON, Canada) with lemavisole (Vector
Laboratories, Burlington, ON, Canada) to inhibit endogenous alkaline phosphatase
activity. Tissues were then dehydrated in ascending ethanol series, cleared with xylene
and mounted with Permount (Fisher Scientific, Toronto, ON, Canada).

2 .5 .3 .

Morphometric analysis

Analysis of pancreatic sections was performed using a Carl Zeiss Axioskop
transmitted light microscope (Carl Zeiss, Inc., New York, NY, USA) with Qlmaging
MicroPublisher 3.3 Real Time Viewing camera (Qlmaging, Burnaby, BC, Canada).
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Digital images were captured at 40X or 20X objective lens, depending on islet size.
Image analysis was performed using Northern Eclipse Version 7.0 morphometric analysis
software (Empix Imaging, Inc., Mississauga, ON, Canada). For each pancreatic section,
the following measurements were determined: total pancreatic area for each section and
area of insulin and glucagon, area occupied by each islet, total area occupied by insulin
positive cells, and total area occupied by glucagon positive cells. The perimeter of cells
of interest was traced and area (pm) was calculated using Northern Eclipse Version 7.0
software. The following calculations were determined:
3-cell mass = total (3-cell area / total pancreatic area x weight of the pancreas
% Beta-cell area = total (3-cell area / total islet area x 100
%

Islet cell area = total islet cell area/total pancreatic area xlOO

2.6. Intraperitoneal glucose tolerance test (IG T T )
At 130 days of age, three to five animals from C and LP3 treatment groups were
subjected to an IGTT. After approximately 14 hours of fasting, animals, were tested for
blood glucose by tail vein lancing and a drop of blood was applied to an Ascensia Breeze

T
'W
glucometer (Bayer Healthcare, Mishawaka, Indianapolis, USA). Animals were then

2

injected in the peritoneal space (i.p.) with a single bolus of 2g/kg glucose. Blood glucose
was taken by lancing the tail vein and monitored at 5, 15, 30, 60, 90, and 120 min post
injection.

2.7. Statistical analysis of data
Data was presented as mean ± standard error of mean (SEM). Unpaired two-tailed
Student’s t-test was used to compare control (C) vs. Low protein (LP) groups. One way
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ANOVA (analysis of variance) followed by Student-Newman-Keuls procedure was used
to compare more than two groups. Also two-way ANOVA followed by Bonferroni’s
post-test. Differences were considered statistically significant at p<0.05. Statistical
analysis was performed using Graph Pad Prism Version 4 (Graph Pad Inc., San Diego,
CA, USA).

V
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Chapter 3: RESULTS

3.1. Effect of Low protein (L P ) diet during gestation on body weight at
birth, weaning and d l3 0 of postnatal life in male rats.
Body weight measurements were performed on day 1 (birth), day 21 (weaning),
and day 130 (dl30) of postnatal life on offspring of control and low protein diet (LP)
treated groups. At birth, all LP groups were pooled in one group as they were similarly
exposed to the LP diet as shown in Figure 2.1. Body weight of offspring bom to LP diet
treated mothers were significantly decreased (4.756± 0.118) compared with control group
(6.94± 0.249) (p<0.001, Figure 3.1 A). At day 21, both LP1 and LP2 groups received the
same diet during pregnancy and lactation, therefore, their weights were pooled in one
group (LP1,2) as shown in Figure 2.1. This LP1,2 group showed a significant decrease
(p<0.001) in body weight compared with C group, and no significant changes were seen
in LP3 compared with C (Figure 3.IB). By dl30, body weight in LP1 and LP2 groups
were still significantly reduced compared to C group, while LP3 group showed a
significant increase (p<0.05) compared with C group (Figure 3.1. C). Therefore protein
restriction during gestation affected offspring body weight at all ages (Figure3.1, A, B,
C).

3.2. Effects of LP diet on P d x l gene expression and protein abundance
at different time points (d21 and d l30) of postnatal life.
Our laboratory and others, showed that the rodent pancreas is not fully developed
until 2-3 weeks after birth and the neonatal period act as an extension of the prenatal
period to further differentiate and maturate P-cells (Hill and Duvillie 2000; Habener,

67

Kemp et al. 2005). In addition, other studies have shown that there is a second wave of (5cells remodeling in rodents after weaning to establish the correct number of functional
and mature p-cells (Finegood, Scaglia et al. 1995). Moreover, we have previously shown
that offspring of LP fed mothers had a significant impairment in glucose tolerance at
dl30 of age (Chamson-Reig, 2009). Therefore, we chose these two time points to
examine the effect of LP on pancreas development and P-cell differentiation and function
by examining the expression and protein abundance of the transcription factor Pdxl.
To determine whether Pdxl gene expression was affected in offspring exposed to
LP diet at d21 and dl30, mRNA was extracted from pancreatic tissues and measured by
quantitative real-time PCR (qRT-PCR). Housekeeping fi-Actin gene expression was used
as an internal control in these experiments.
We found no significant changes in the levels of Pdxl mRNA expression in LP
groups compared with control at d21 males. The C group at dl30 showed significant
increased in Pdxl gene expression over the time as compared with C group at d21, but
LP groups did not show significant changes over time compared with d21 control group.
When comparing the level of Pdxl gene expression in LP groups at dl30 with its C, it
showed a significant decrease (p<0.05, Figure 3.2). These results suggest that the impact
of the LP diet continued after weaning despite the diet changed to C diet in LP3. On the
other hand, the female offspring did not show significant change in Pdxl gene expression
compared with C either at d21 or dl30 but the levels of Pdxl expression were
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significantly increased over time in all groups at d 130 compared with C group at d21
(Appendix 3).
In addition, Pdxl protein expression was determined by Western blot from 3-4
different samples from each group; one female and one male from each treatment at d21
(Figure 3.3). Analysis of the bands was performed by densitometry and their intensity
was calculated using Gene Tools computer software and expressed as mean ±SEM. No
significant changes (p > 0.05) were detected in Pdxl protein abundance in neither of the
LP1,2 and LP3 groups when compared to C group in males (Figure3.3 B) or females
(Appendix 4 B).
Also, Pdxl protein abundance was examined in samples from different groups at
dl30 (Figure 3.4). A significant (p<0.05) decrease in Pdxl protein abundance was
observed in males in LP1 (1.48 ± 0.18), LP2 (1.98 ± 0.182) and LP3 (0.987 ±0.17)
compared with C group (4.09 ± 1.2) (Figure 3.4 B). On other hand, females Pdxl protein
abundance was not affected by LP diet at this age dl30 (Appendix 5.B))

3.3. Effect of LP diet on P d x l downstream target genes at d21.
In |3-cells, Pdxl regulates a number of genes involved in maintaining |3-cell
identity and function. In this study we focused on the downstream target genes that are
involved in glucose-homeostasis (i.e., insulin, GK and GLUT2).
Western blot analysis did not show any significant changes in insulin protein
abundance in either LP1,2 or LP3 groups as compared to the control group at age d21 in
male (Figure 3.5) and female (Appendix 6). We also used western blots to examine the
other downstream protein of Pdxl including GK and GLUT2. Neither GK nor GLUT2

proteins expression showed any significant changes in LP1,2 and LP3 groups when
compared to C group after being normalized to the internal loading control (P-Actin, p >
0.05) (Figure 3.6; 3.7). Similarly, we did not detect any significant changes in female
offspring at d21 time of age (Appendix 7, 8).

3.4. Effect of L P diet on P d xl downstream target genes at dl30.
3 .4 .1 .

Insulin as the first target gene o f Pdxl

As shown above 130 day offspring from the LP diet demonstrated decreased
expression of Pdxl gene and protein. We therefore hypothesized that level of the
downstream target proteins may also change.
Insulin was first studied as it regulates glucose homeostasis. Insulin gene expression
was examined using qRT-PCR to compare LP1, LP2 and LP3 groups with C group. The
results showed a significant decrease in insulin gene expression in the LP1 and LP3
groups compared with C group (p<0.05), while no significant changes were observed in
the LP2 group (Figure 3.8 A).

v

Insulin protein abundance was also examined using Western blot. Insulin protein
abundance showed a significant decrease in male animals of the LP1 (1.55± 0.598, n=3)
and LP3 (1.043 ±0.112, n=4) groups as compared to C group (2.43±0.31, n=4) (p<0.05),
while no significant changes in LP2 group (2.68 ±0.33, n=3) compared with male C
group was observed (Figure 3.8. B). In female groups, however, insulin protein did not
show any significant change (Appendix 9 A, B).
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So far, our data showed that female offspring were not affected by LP diet, at
least at this age. Therefore, we have chosen to focus on the LP male rats as they showed
changes in Pdxl and insulin expression for the rest of our experiments.

3 .4 .2 .

Effect o f the LP diet on GLUT2

Quantitative RT-PCR was performed to examine the effect of the LP diets at
different windows of development on the expression of GLUT2 mRNA. The results
showed a significant decrease in GLUT2 gene expression in male LP3 groups as
compared to C group (P<0.01), while no change in LP1 and LP2 Groups compared with
C group was observed (Figure 3.9 A). Experiments were also performed to determine if
the level of GLUT2 protein abundance was affected. Analysis of band intensities showed
no significant change (p > 0.05) in LP1 and LP2 groups compared to C which agrees with
the results we obtained on gene expression. The level of GLUT2 protein abundance in
male LP3 group, however, was decreased as compared to C groups (p<0.05) (Figure 3.9

3 .4 .3 .

Effect o f LP diet on GK

Glucokinase (GK) is one of the downstream target genes for Pdxl and it is the
glucose sensor, which has an important role in the glucose homeostasis. Therefore, we
examined GK protein abundance by Western blot. The 50 KDa protein representing GK
was detected in all tissue extracts. No significant changes were observed in GK protein
abundance in LP1, LP2 or LP3 male groups compared with C groups (Figure 3.10).
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3.5. Effect of L P diets at different windows of development on P d xl
cellular localization
It has been shown that the localization of Pdxl protein in p-cells has an important
role in the regulation of gene transcription; high glucose levels enhance Pdxl nuclear
translocation which has a positive effect on insulin gene transcription (Macfarlane, 1999;
Ardestani, 2011). Our experiments have shown a decrease in Pdxl gene and protein
expression in LP diet treated animals, although the Pdxl was altered in all male LP
groups, the more significant changes in Pdxl downstream were observed mainly in LP3
groups.
It has also been shown that Pdxl nuclear localization is important for its function as
the nuclear Pdxl represent the active and functional fraction of the protein. Consequently,
nuclear localization of Pdxl is more important than the level of its expression as a
reflection of protein activity (Ardestani, 2011).

Therefore, sub-cellular fractionation

followed by Western blots was performed to examine nuclear and cytoplasmic
localization of Pdxl protein.

v

There was a significant decrease in the nuclear localization of Pdxl protein in LP3
group (P<0.05) compared with C group; however, nuclear localization of Pdxl in LP1
and LP2 did not show any significant changes as shown in Figure 3.10. A/C. On other
hand, LP3 groups showed significant increase in the cytoplasmic localization of Pdxl
protein opposed to LP1 and LP2 groups where the cytoplasmic Pdxl was significantly
decreased as compared to C group (Figure 3.1 l.B/D).
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3.6. Effect of LP diet on Glucose tolerance in LP3 group offspring at
d 130 of postnatal life.
Since Pdxl protein nuclear localization in LP3 group was significantly decreased
compared to control groups, we conducted glucose tolerance test for this group to
determine any disturbance in glucose homeostasis which could be related to possible
changes in insulin synthesis and secretion. After approximately 14 hours of fasting,
animals were tested for fasting blood glucose. Blood glucose levels were monitored at 5,
15, 30, 60, and 120 minutes post-injection. Fasting blood glucose (FBS) was high in LP3
group (7.9± 0.95 mmol/L). As shown in Figure 3.12.A, glucose level showed persistent
high levels after 2 hours from glucose injection. Area under curve was calculated and
analyzed using unpaired t-test and showed a significant increase (p<0.01) in LP3 group
(3167± 96.23) as compared with C group (1875 ± 200) (Figure 3.12.B).

3.7. M orphological changes in LP3 group pancreata compared with C
group
Since the Pdxl gene and protein expression as well as its nuclear localization was
significantly decreased in LP3 group compared to control groups at dl 30 of age and
importantly glucose was impaired; we examined if these changes also impacted islet
structure and distribution of endocrine cells. A morphometric and quantitative analysis of
islet cell area, P-cell area and P-cell mass were performed (Figure 3. 13, A-E). The results
showed that the percentage of total P-cell area to total islet area were significantly
decreased in LP3 group (46.37 ± 2.656) compared with C group (69.14 ± 6.475)
(p<.0.05) (Figure 3.13.C)
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Also, the percentage of total islet area to total pancreatic area was significantly
decreased in LP3 group (23.63 ± 2.85) compared with C group (36.7± 3.229) (Figure 3.
12. D). LP3 group also showed a significant (p<0.05) decrease in P-cell mass compared
with C group (Figure 3.13. E).
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Figure 3.1: Body weight at day 1,21, and dl30 in male rats. (A) At dl all LP group
were pooled as they were exposed to the same conditions. Body weight of offspring bom
to a LP diet treated mothers (black bar) were significantly decreased compared with
control group (white bar) at birth (dl), *** pO.OOl. (B) At d21 (weaning), as both LP1
and LP2 groups received the same diet during pregnancy and lactation (at d21) data of
the two groups were pooled under one group (LP1,2). LP1,2 groups (grey bar) showed
significantly reduced body weight compared to control group (white bar) at d21 but LP3
group (black bar) did not show significant change. (C) At dl30, LP1 (grey bars) and LP2
(dark grey bar) offspring maintained a significant decrease in body weight mean while
the LP3 group (black bar) showed a significant increase in weight. Eight to 20 animals
were tested per group and measurements were expressed as mean±SEM in grams and
significance was determined using Student’s T-test. *p<0.05, **p<0.01, ***p<0.001 vs.
Control.

d130

O

M
O
O

Body weight (g)

O

as

vi
o
o

K>
Q
O

1____ 1____

W
Pi
o

o
o

d1

d21

in
o
o

g
o

>

Body weight (g)
O P N J W ^ U t f l l v J O O

I__ I__ 1__ L_J__ I__ I__ I__ I

____1__- J ____1____ 1

I

o

H

o

LP1

*
i#
#

LP2
LP3

*
#
#

Ui

1

76

Figure 3.2: Gene expression of Pdxl in LP male groups at d21 and dl30.

Pdxl

mRNA levels in samples from C (white bar), LP1,2 (grey bar) and LP3 (black bar)
\

groups offspring at d21 (left side of the graph, n=6-9) and samples from C (white bar),
LP1 (gray bar), LP2 (dark grey bar) and LP3 (black bar) at d 130 (right side of the graph,
n=6-9). No significant differences were detected among LP groups as compared to C
group at d21. Pdxl mRNA levels were increased in C group at d 130 as compared to C
group at d21 (#: p<0.05). However, Pdxl mRNA levels were decreases in all LP groups
at dl30 compared to their control (*: p<0.05). Two -way ANOVA followed by
Bonferroni’s post-test for multiple comparisons was performed to determine degrees of
significance.
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Figure 3.3: \^estern blots for Pdxl protein abundance in male groups at d21. (A)
Representative Western blot for Pdxl protein on samples from control (C), LP1,2, and
LP3 groups. (B) Graph representing the results of 4 western Blots. Protein abundance
was calculated relative to the internal control (P-Actin). No significant difference was
observed in the amount of Pdxl protein expression in samples from C, LP1,2 and LP3
groups’ offspring. One-way ANOVAs followed by Newman Keuls was performed to
compare C (white bar), LP1,2 (gray bar) and LP3 (black bar) groups (n=4-5).
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Figure 3.4: Western blot analysis for Pdxl protein from male offspring at dl30. (A)
Representative western blot of Pdxl protein levels and P-Actin from pancreatic tissue of
\

dl30 male groups C, LP1, LP2 and LP3. (B) Graph representing results obtained from 4
different western blots. Quantification of bands intensities revealed significant (*p<0.05)
decrease in Pdxl protein abundance in LP1 (grey bar), LP2 (dark grey bar) and LP3
(black bar) groups compare with C (white bar) group, mean±SEM; n=3-4 difference
among C (white bar), LP1, 2 (grey bar) and LP3 (black bar) groups as determined by one
-way ANOVA followed by Newman-Keuls.(n=4).
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Figure 3.5:\Western blot analysis of insulin protein levels in male groups at d21. (A)
Representative Western blots for insulin and the internal control (3-Actin. (B) Graph
summarizing the results of 4 separate membranes. One -way ANOVA followed by
Newman-Keuls was performed to compare C (white bar), with LP1, 2 (gray bar) and LP3
(black bar) groups. Data expressed as mean±SEM as relative to the internal control |3Actin, n=3-4. Diet did not affect insulin protein at d21.
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Figure 3.6 ¡ Western blot analysis for GLUT2 protein in male groups at d21. (A)
Representative western blot of GLUT2 protein levels and P-Actin from pancreatic tissue
of d21 male groups C, LP1,2 and LP3. (B) Quantification of bands intensities of 4
different blots revealed no significant difference among C (white bar), LP1,2 (grey bar)
and LP3 (black bar) groups as determined by one -way ANOVA followed by NewmanKeuls.(n=4).
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Figure 3.7:\Western blot for GK protein abundance from male group at d21. (A)
Representative Western blot of GK protein expression levels from pancreatic tissue of
d21 male groups C, LP1,2 and LP3 groups. (B) Representative graph of results obtained
from 4 different western blots. Quantification of bands showed that LP treatment did not
have any significant effect on GK protein level at d21, n=3-4. One -way ANOVA
followed by Newman-Keuls.
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Figure 3.8: Gene expression and protein abundance of insulin from male groups at
dl30 of offspring age. (A) Insulin mRNA level from C, LP1, LP 2 and LP3 groups at
dl30 (N=6-9) was measured using qRT-PCR. A significant decrease in insulin mRNA
expression in LP1 (grey bar) and LP3 (black bar) groups compared to C (white bar)
group was detected. However, no significant change was seen between C and LP2 (dark
grey bar) group as confirmed by One -way ANOVA. (B) Representative Western blot for
insulin protein abundance in the different treated groups. (C) Densitometry of bands
revealed a significant decrease in insulin protein expression in LP1 and LP3 groups
compared to C group (*p <0.05). However, no significant change was found in LP2
group compared to control. Bars represent means ± SEM; n=3-5.
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Figure 3.9: Gene expression and protein abundance of GLUT2 in male groups at
dl30 of age. (A) Real-time-PCR was performed to examine the effect of diet insult on
expression GLUT2 mRNA at different windows. The results showed significant decrease
in GLUT2 ^ene expression in male LP3 group compared with C group (P<0.01), while
no change was observed in LP1 and LP2 Groups compared with C group. (B)
Representative western blot of Pdxl protein levels and P-Actin from pancreatic tissue of
dl 30 male groups C, LP1, LP2 and LP3. (C) Graph representing results obtained from 4
different western blots. Quantification of bands intensities revealed significant decrease
in GLUT2 protein expression in LP3 group (**p<0.01) as confirmed one-way ANOVA
followed by Student-Newman-Keuls but no significant change was found in LP1 or LP2
groups compared with C group.
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Figure 3.10? Western blot analysis for GK protein from male offspring at dl30. (A)
Representative western blot of GK protein levels and P-Actin from pancreatic tissue of
dl30 male groups C, LP1, LP2 and LP3. (B) Graph representing results obtained from 4
different western blots. Quantification of bands and one -way ANOVA statistical test did
not show any significant affect of LP diet treatment on GK protein levels at d 130; n=3-4.
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Figure 3.11: Nuclear localization of Pdxl by LP diet at dl30. (A) Nuclear and (B)
cytoplasmic fractions of pancreatic samples were subjected to Western blot using
antibodies against Pdxl, Histone H3 and tubulin. The two latter proteins were used as
markers of the nuclear and cytoplasmic fractions, respectively. Densitometric analysis of
band intensities of nuclear (C) and cytoplasmic (D) fractions revealed a significant
decrease in Pdxl protein nuclear localization mainly in LP3 group compared with C
group; however, nuclear localization of Pdxl in LP1 and LP2 did not show any
significant change. On other hand, LP3 groups showed significant increase in
cytoplasmic localization of Pdxl protein whereas LP1 and LP2 groups showed a
significant decrease compared with C group (* p<0.05), N=3-4.

95

Nuclear fraction

C LP1 LP2 LP3
Pdx1-f «I

B

Cytoplasm Fraction

C LP1 LP2 LP3

«k

H is H 3 ^

Tub#,

C

/

LP1

LP2

LP3

C

LP1

LP2

LP3

96

Figure 3.12t Intraperitoneal glucose tolerance test. (A) Intraperitoneal glucose
tolerance test (IGTT) was performed on male offspring of LP3 group (closed circles) and
C group (open circles). (B) Area under curve (AUC) was calculated and analyzed using
unpaired t test. Data is presented as Mean ± SEM (n=3). A significant increase
(**p<0.01) in area under curve in LP3 group (black bar) compared with C group (white
bar).
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Figure 3.13: Morphological changes in p-cell area, P-cell mass and islet area in LP
diet treated group. Beta cell area relative to endocrine area was significantly reduced in
LP3 animals at 130 days compared with C group (p<0.05). Sample control (A) and LP3
(B) micrographs of pancreatic islets are illustrated, where brown represents glucagonproducing cells (arrow, alpha cells in periphery) and pink/red indicates insulin-producing
cells (arrow, beta cells in core). Immunohistochemistry morphological analysis also
showed a significant statistical difference between LP3 (black bars) and control (white
bars) groups in P-cell mass and islet cell area. Data is presented as means ± SEM as a
percentage of endocrine area, derived from 3 or 4 animals per group. Magnification bar
= 100pm. P-cell area mass, islet cell area and p-cell area were significantly decreased
(*p<0.05) in LP3 group compared with C group (C, D and E, respectively).
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Chapter 4: DISCUSSION

During fetal development the intrauterine environment profoundly affects fetal
growth and birth weight. David Barker and his colleges were the first to show the
association between low birth weight (LBW) and the development of adult chronic
diseases such as type 2 diabetes mellitus (T2DM) (Hales, Barker et al. 1991).
The connection between LBW and T2DM has been attributed to impaired P-cell
function (Hales, Barker et al. 1991; Wills, Watson et al. 1996). These changes seem to
develop during the plastic stage of fetal development when the fetus is experiencing rapid
cell proliferation (McCance 1974). The period varies for different organ systems and
consequently developmental programming could occur at various times including
conception, fetal life and infancy (Ozanne and Constancia 2007).
Administration of a LP diet during pregnancy in rats has been studied extensively
and lead to LBW in offspring with an important impairment of pancreatic development
within the endocrine compartment (Snoeck 1990). Our laboratory, along with others,
found an increase in islet cell apoptosis with decrease P-cell mass and diminished islet
vascularity, with decreased islet cell area in pancreas of offspring of LP fed mother
during gestation and lactation (Petrik, Reusens et al. 1999; Holemans, Aerts et al. 2003;
Heywood, Mian et al. 2004). Also, these offspring developed impaired glucose
homeostasis at dl30 (Chamson-Reig, Thyssen et al. 2009). In addition, it has been
showed that the effect of nutritional challenge depended on the timing or the critical
period of food insult where any nutritional challenges during pregnancy in early-, mid- or

late-gestation will have different effects on the placenta and fetal weight (Villar and
Belizan 1982; Painter, Roseboom et al. 2005). Previously, we also showed that the LP
diet given during different developmental windows of pregnancy (early middle and late
or throughout pregnancy) have different outcomes on the health of the offspring. In this
study we found that the LP diet during middle and late pregnancy has higher effect on the
offspring morbidity at d21 than LP throughout pregnancy. In rodent, many organs are not
fully mature at birth; therefore the neonatal period act as an extension of the prenatal
period and it is necessary for further differentiation and maturation of organs (Petrik,
Arany et al. 1998; Butler, Janson et al. 2003). Hence, many studies agree that the
postnatal period is critical for overall growth (Zambrano, Rodriguez-Gonzalez et al.
2005; Zambrano, Bautista et al. 2006; Pinheiro, Salvucci et al. 2008). p-cell area and the
transcription factor Pdxl were decreased at d21 of age in LP diet during middle and late
pregnancy while there was no much such effect when the insult occurs throughout
pregnancy (Chamson-Reig, Thyssen et al. 2006).
The main objective of this study was to further understand the mechanisms of the
effect of LP diet on the impairment of P-cells and the development of T2DM later in
adult life, by examining the expression of Pdxl gene and its downstream target and their
contribution to the maintenance of glucose homeostasis. We also exposed the animals to
LP diet during different time periods of neonatal and postnatal life to determine the
critical period of pancreas development on homeostasis affected by maternal nutrition.
Growth restriction and LP diet exposure at different time points during the life of
the offspring.
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Maternal LP diet has an intense effect on fetal growth resulting in offspring with
LBW (Snoeck, Remade et al. 1990; Ozanne and Hales 1999). Our animal model with
maternal LP diet also showed decrease in birth weight compared with animals fed with
regular diet (20% protein content, control). Postnatal diet appeared to play a major role in
determining subsequent growth. Animals fed with LP diet throughout pregnancy and
lactation until weaning showed reduction in body weight at d21, an observation that was
also noted by Desai and his group (Desai, Crowther et al. 1996). These results were also
seen in animals continued to be fed with LP diet (gestation and lactation, LP1 and LP2)
as they showed a significant decrease in body weight compared with control animals. On
other hand, the LP3 offspring that had a control diet during lactation had a rapid catch-up
during this period although not significantly different to the group that had C diet. Catch
up growth immediately after dietary deprivation could be the key for obesity in adult life
(Bieswal, Ahn et al. 2006; Pinheiro, Salvucci et al. 2008). Previous studies have shown
that LP3 group had a 20% higher fasting blood sugar (FBS) compared C group and 15%
than LP2. In addition, fat mass in LP3 was 30 % higher than C and 150°)o than LP2 at 6
months of age (Pinheiro, Salvucci et al. 2008). Our results confirmed the observations of
these studies where the body weight of LP1 and LP2 was significantly decreased while
LP3 group animals had a body weight significantly increased compared with C group
with C at dl30 the animals. Poor nutrition in utero followed by postnatal catch-up growth
(LP3) results in an accelerated cellular aging by islet telomere shortening (Tarry-Adkins,
Chen et al. 2009). Also, it has been shown that fetal growth restriction followed by rapid
postnatal weight gain, accelerated early postnatal catch-up is associated with increased
susceptibility to obesity and diabetes in adult life (Eriksson, Forsen et al. 2002; Barker,
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Eriksson et al. 2005; Ong 2006). On other hand, prevention of postnatal catch-up growth
normalized both glucose tolerance and obesity (Jimenez-Chillaron, Hernandez-Valencia
et al. 2006).
Alteration of Pdxl expression in the different LP animals treatments are age and
gender dependent
In the developing pancreas, Pdxl is involved in both pancreas formation and Pcell differentiation. In mature P-cells, Pdxl transactivates insulin and other p-cell-related
genes such as GLUT2 and GK. Pdxl plays an important role in the induction of insulinproducing cells in various non-P-cells and is thereby a possible therapeutic target for
diabetes (Kaneto, Miyatsuks et al. 2008). Under diabetic conditions, expression and/or
activity of Pdxl in P-cells are reduced, which leads to suppression of insulin biosynthesis
and secretion. Attenuation of Pdxl promoting effect on certain genes may explain, even
partially, the mechanism of P-cell dysfunction in diabetes. Therefore, it represents a
strong candidate to study in the LP model. We sought to determine the effect of LP on
Pdxl downstream target genes that were involved in glucose homeostasis (insulin,
GLUT2 and GK).
Many studies support our data showing that the LP diet (during gestation and/or
neonatal life) effects on offspring is age and gender-dependent. Our data and other
studies showed impairment in GTT at 130 days (Chamson-Reig, Thyssen et al. 2006) in
LP2 offspring while older studies have shown a fully blown diabetes by 17 month in
males and in female occurred by 21 month of age (Arluison, Quignon et al. 2004;
Femandez-Twinn, Wayman et al. 2005).

Furthermore, the hypothesis that proposed the development origins of adult
disease states that environment and nutrition during critical periods in development of an
individual can have a long lasting impact on organ structure and function and will affect
the pattern of adult disease (Barker, Osmond et al. 1989). In our results, no significant
changes were observed in the level of Pdxl mRNA expression in LP groups compared
with control at d21 males. The C group at dl30 showed significant increased in Pdxl
gene expression over time as compared to d21 C group, although LP groups did not show
significant changes over time compared with d21 control group. However, the level of
Pdxl gene expression showed significant decrease at dl30 compared with the C at the
same age and that means LP diet effects the expression of Pdxl. These results suggest
that the impact of the LP diet continued after weaning even when the diet was changed to
C diet in LP2 and LP3 groups. At d21 Pdxl protein abundance did not show significant
change in LP compared with C, while it showed significantly decrease at dl30 in all LP
groups. Also, other protein including insulin, GLUT2 and GK did not show any
significant change in either males or females groups at d21. LP male rats showed
significant decrease in Pdxl gene expression at d 130 compared with its control, although
it did not show significant change compared with d21 control. A study by Sugden et al.,
demonstrated that gender-specific insulin sensitivity in 20 week old rats offspring
exposed to protein restriction in early life (LP2) was observed only in males and this
change occurred in adult life (Sugden and Holness 2002). Early studies have shown that
early protein restriction had more effect in males than females where males were more
vulnerable compared to females to developing obesity (Anguita, Sigulem et al. 1993),
hypercholesterolemia and triacylglycerolaemia (Lucas, Baker et al. 1996). Similarly, in

this study, the effect of LP diet was gender-specific. Our study showed that female
offspring in all treatment groups did not show changes in expression of Pdxl or its
downstream target genes including insulin, GK, and GLUT2 at age d21 and d l30. It
could be that the changes will show later in life and this may be due to hormonal
protection. A study done by Ozanne, has shown that females treated with LP2 diet
develop glucose intolerance at 21 months of age (Femandez-Twinn, Wayman et al.
2005). Furthermore, it has been hypothesized that estrogen may have a direct effect on
secretion of insulin by the pancreas, as estrogen receptors are present in pancreatic (3-cells
(Sutter-Dub MT, 2002), and estrogen increases the release of insulin in (3-cell culture
models (Nadal, Ropero et al. 2004). Moreover, it has been shown that the hormonal
therapy used in menopausal women reduced the risk of T2DM (Pentti, Tuppurainen et al.
2009) and Keju-Shi and this group showed that orchiectomy significantly reduced
development of the T2DM in rat males, whereas ovariectomy enhanced its development
in rat females (Shi, Mizuno et al. 1994). We have also shown in previous studies in our
laboratory that the LP2 diet mainly affects males at dl30 and they had lower hormone
testosterone levels (Chamson-Reig, Thyssen et al. 2009) and that might explain why LP2
group are less affected compared with LP3 group.
Although female groups in this study did not show any change in Pdxl or its
downstream targets, male groups showed a decrease in Pdxl expression compared with
C. Staffers and colleagues have shown progressive reduction of Pdxl expression in
IUGR rats model which induced by bilateral uterine artery ligation (Staffers, Desai et al.
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Nuclear localization of Pdxl altered by LP diet at different windows
Because of the observed decrease in the expression of Pdxl gene and protein in
all male groups, we hypothesized that the downstream signal proteins may also change as
a result, which may explain the glucose intolerance seen. It is known that insulin
expression and its transcriptional regulation involve Pdxl (Le Lay, Matsuoka et al. 2004;
Iype, Francis et al. 2005) as it interacts with other proteins at the insulin promoter such as
(32/Neuro D l, E47/Panl, p300 co-activator and Bridge-1 (Thomas, Yao et al. 1999;
Ohneda, Mirmira et al. 2000; Qiu, Guo et al. 2002). Also, the GLUT2 promoter is
controlled by the Pdxl homeobox factor (Waeber, Thompson et al. 1996; Lottmann,
Vanselow et al. 2001). The reduction of Pdxl expression either genetically or acquired
has been shown to cause T2DM and (3-cell dysfunction (Stoffers, Ferrer et al. 1997;
Kulkami, Jhala et al. 2004; Brissova, Blaha et al. 2005; Holland, Gonez et al. 2005). The
localization of Pdxl in J3-cells has an important role in the regulation of gene
transcription. Consequently, nuclear localization of Pdxl is more important than the level
\

of overall gene expression as it is indicative of the protein activity (Ardestani, Sauter et
al. 2011). Moreover, it has been shown that translocation of Pdxl to the nucleus leads to
insulin gene transcription (Elrick and Docherty 2001) while Pdxl shuttling to the cytosol
will impair insulin secretion (Robertson 2006). Therefore, we speculated that the results
of this study could be explained by its cellular localization. Whereas Pdxl gene
expression was decreased in all male LP groups, the downstream target genes of Pdxl
were mainly reduced in the LP3 group as it had less nuclear localization compared with
the other groups. On other hand, in LP1 and LP2 animals Pdxl localization to the nucleus
was not different from the controls.
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Inactivation of Pdxl in mice leads to loss of islet cell phenotype and a reduction
of insulin and GLUT2 expression that leads to diabetes (Ahlgren, Jonsson et al. 1998). In
the Zucker diabetic rats, the expression of GLUT2 is reduced in the islets and therefore
they have loss of glucose-induced insulin release, and develop obesity and T2DM
between weeks 7-9 after birth (Johnson, Crider et al. 1990). In addition, a study by
Ohneda showed that GLUT2 gene expression was decreased in P-cells in diabetic animals
(Ohneda, Ohneda et al. 1993). GLUT2 has a role in glucose-induced insulin secretion
(Unger 1991). In our present study, there was a reduction in the expression of GLUT2 in
LP3 males at 130 days of age that also showed a significant IGT compared to other
groups where GLUT2 was not changed. Previous studies have shown that LP3 had 20%
higher fasting blood sugar (FBS) than C and 15% higher than LP2 at 6 months (Hoet
1991; Pinheiro, Salvucci et al. 2008).
In addition, studies have shown that reduced in GLUT2 expression in p-cell
strongly impaired glucose signaling of insulin secretion and synthesis (Guillam, Dupraz
et al. 2000). In the present study, our LP1 and LP3 males had reduced insulin gene
expression. After glucose uptake by GLUT2 in p-cells, glucose is phosphorylated by GK
to glucose-6-phosphate. We found that GLUT2 was reduced in LP3 males. In this case,
glucose may fail to enter the cells and GK remains inactive. We know that GLUT2 is a
glucose transporter that transports glucose into the P-cell; glucose in P-cell stimulates the
phosphorylation of Pdxl (Serup, Jensen et al. 1996; Macfarlane, McKinnon et al. 1999)
leading to translocation of Pdxl to the nucleus which helps in transactivating genes
including insulin and GLUT2. Therefore, decrease in GLUT2 will effect activation of
Pdxl and insulin synthesis and secretion. On the other hand, decreasing activation of
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Pdxl (nuclear localization) will lead to decrease in GLUT2 and other gene
transactivation. This may explain the change that occurred in LP3 group; however, the
question here is whether GLUT2 decreases due to decrease Pdxl nuclear localization or
that Pdxl nuclear localization occurs as a result of decrease in GLUT2 expression.
In Figure 4.1, we suggest the mechanism by which the development of DM may
occur in LP3 males. As we mentioned before, Pdxl regulates p-cell maturation and
function, therefore the decrease in Pdxl gene expression in LP3 group results in decrease
in P-cell mass, P-cell area and islet cell area. Moreover, the reduction in GLUT2 as seen
in our experiments may cause reduction in glucose transport to P-cells and reduction of
Pdxl nuclear localization leading to a decrease in insulin gene transactivation by Pdxl as
well as decreased insulin secretion through GSIS.
Summary
In Table 4.1, we show that the LP diet during gestation leads to LBW and this
effect is gender- and age-specific. At d21 rats treated with LP1,2 diets were underweight
compared with C group, while LP3 group showed a slight increase in body weight
compared with C group. Gene expression in Pdxl and its downstream target genes
(insulin, GLUT2 and GK) at the same age did not show significant changes in either
gender.
At d 130, LP3 was overweight compared with all other groups which emphasize
that catch-up growth immediately after dietary deprivation could be the key for obesity in
adult life. LPland LP2 showed significantly lower weight gain compared with C group.
In male LP3 group Pdxl was mainly cytoplasmic which may affect its downstream
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signaling and cause reduction in insulin and GLUT2 expression. Also, LP3 group showed
higher FBS with impairment in IGTT and decrease in (3-cell mass and area and islet area.
In LP1 and LP2 groups, although Pdxl cytoplasm localization was reduced, there was no
significant change in the nuclear localization.
Conclusion
Our study demonstrated very clearly that LP diet has different effects on offspring
and that is dependent on the time of insult, age of offspring, and sex. It showed that
dietary insults during different windows of fetal and neonatal development produced
different phenotypes of glucose impairment. Also, we showed that LP diet during
gestation followed by C diet during lactation leads to rapid postnatal weight gain and
accelerated early postnatal catch-up, and that is associated with obesity and diabetes in
adult life. We also presented evidence that postnatal period plays a major role in
determining the consequence of LP diet on fetal growth. In addition, we provided
evidence that nutritional challenges during different windows of development are genderspecific. Our data also shows that transcription factors involved in the maintenance and
function of beta cells (Pdxl and its downstream genes) are altered in protein restricted
diets leading to development of disease in adulthood.
These major findings have helped shed some light on the mechanism by which the
intra-uterine environment can influence the predisposition to an important chronic disease
and its associated pathophysiological changes in susceptible individuals. We are very
optimistic that such a study, by providing further understanding of the etiology of
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diabetes mellitus, will be a strong foundation upon which successful strategies for
prevention and treatment of this devastating illness can be built.
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Table 4.1. Summary of findings in LP1, LP2 and LP3 male groups at dl 30.
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Figure4.1:Schem
aticrepresentationoftheeffectsofLPdietonP-cellfunctionand
insulinsecretion.LP diet during pregnancy followed by normal diet leads to decrease in
Pdxl gene expression and this will lead to decrease in GLUT2 which finally will effect
Pdxl activation (nuclear localization) and this will lead to decrease in insulin synthesis
and secretion. Glucose is uptaken to P-cell by GLUT2 transporter and then metabolized
to generate ATP. Imbalance in ADP/ATP levels inhibits ATP-dependent K+ channel
causing membrane depolarization and opening of voltage-dependent Ca
resulting in increase in intracellular Ca

channels

necessary for exocytosis and release insulin to

the extracellular space. Glucose regulates Pdxl nuclear localization through p38/SAK2
pathway. PI3K, Phosphatidylinositol 3-kinase; SAPK, stress-activated protein kinase.
Adapted from (McKinnon and Docherty 2001)
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Appendix 1: Animal Care Protocol A. All animal procedures were performed with the
approval of the Animal Care Committee of the University of Western Ontario in
accordance with the guidelines provided by the Canadian Council for Animal Care.

1 1 .0 1 .0 9
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Dear Dr.

Hill
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Fetal programming and pancreatic development

has had its yearly renewal approved by the Animal U se Subcommittee.
This approval is valid from 1 1 .0 1 .0 0 to 1 0 .3 1 .1 0
Th e protocol num ber for this project remains as 2006*088
1. This num ber must be indicated when ordering animals for this project.
2. Animals for other projects m ay not be ordered under this number.
3. If no number appears please contact this office when grant approval is received.
\
If the application for funding is not successful and you wish to proceed with the project, request that an internal
scientific peer review be performed by the Animal U s e Subcommittee office.
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Animal Care Protocol #2006-088* 10: Summary
E tm L E E M m m rtM „iw l * a n sm a k,
May 26. 2006
(Previous protocol # 2002-022-02)
Main Objective: D iam in e how dietary manipulations (specifically tow protein diet)
dining pregnancy and neonatal life will alter pancreatic development..
Personnel listed: Aaron, Christine, Brenda. Edith, Kelly. Mike.
Animals listed: mice: BalbC adults and pups
Rats: Wistar adults and pups
Housing location:

UHR1

Treatments listed:

Agent

Other procedures:

Islet isolation - adult rats
STZ treatment o f neonate mice
Glucose measurement
BrdU injeettons (rats) prior to sacrifice

use
Anaesthesia - kctamtne/jiylasiine
Breeding
Luthanasta
Fasting
Injections
Observation/moni taring
Blood collection
Tissue collection
Dietary Manipulation
Treatment

November 1.2008
Only change in staffing
Staff listed:
David, Edith, Brenda, Kelly, Aaron, Mike
New staff added:
Michelle
Protocol Renewal date: October 2 1 ,2009
Only change in staffing
Staff removed:
Kelly and Mike
Staff added:
Awatif Abu/gaia
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Appendix 2: Comparison of the quality of RNA extracted from pancreatic tissue

storedin
freshtissue,andtissuestoredbysnap-freezinginliquid
nitrogen.We obtained the best quality RNA from tissue stored using KNAlater reagent.
The other techniques caused degradation of RNA. A
:2% agarose gel clearly showing
K N A la te r ,

\

18S and 28S RNA bands visible in the intact RNA sample while the degraded RNA
appears as a lower molecular weight smear.

B:Samples from different tissue were also

analyzed at London Regional Genomics Centre to determine RNA quality and
concentration determination using an Agilent Bioanalyzer. Only samples that had an
RNA Integrity Number (RIN) of 7 or greater were used for qRT-PCR.
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41(dilul:3)

63(dilul:l0)

RNA Area:
RNA Concentration:

S08.9
204ng/p)

RNA Area;
RNA Concentration:

613.0
245 ng/pl

rRNA Ratio [M s / 18s):
RNA integrity Number (R1N):

U
8.3 (8.02.07)

rRNA Rato (28s /IB s):
RNA Integrity Number (RIN):

0.5
5.3 (B.02-07)

RIN: 8.30

Resuit Flagging Color:
Result Flagging label:

RIN: 5.30

cm

Resuit F>agg:ng Color:

Result Flagging label:
Fragment table for sample 6

Fragment table for sample 7

Name

Start Time [s] End Tim e [s ] Area

% of total Area

Name

Start Tim e [s ] End Time [s ] Area

% of total Area

18S
28$

4012
46,93

14 1

18S
28S

3S.85
46 07

78
41

42.10
4«5?

71.5
841

18.5

42.52
48 11

46 5
25.0
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Appendix 3: Gene expression of Pdxl female groups at d21 and dl30. P d xl m R N A
levels in samples from C (white bar), LP1,2 (grey bar) and LP3 (black bar) groups
\

offspring at d21 (left side of the graph, n=6-9) and from C (white bar), LP1 (gray bar),
LP2 (dark grey bar) and LP3 (black bar) at d310 (right side of the graph, n=6-9). LP diet
did not show any effect on Pdxl gene expression at both ages in female, However, Pdxl
mRNA level were found to be increased at d l30 in all groups compared with C at d21
(p<0.05). Two -way ANOYA followed by Bonferroni’s posttest for multiple comparisons
was performed to determine degrees of significance.
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Appendix 4^ Western blot for Pdxl protein from female groups at d21. (A)
Representative Western blot of Pdxlprotein levels and P-Actin from pancreatic tissue of
d21 female groups from C (white bar), LP1,2 (gray bar) and LP3 (black bar). (B) Graph
representing results obtained from 4 different western blots. Quantification of bands and
one -way ANOVA statistical test did not show any significant affect of LP diet treatment
on Pdxl protein level, n=3-4.
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Appendix 5: Western blot for Pdxl protein from female offspring at dl30. (A)
Representative western blot of Pdxl protein levels and (3-Actin from pancreatic tissue of
dl30 female groups. (B ) Quantification of band intensity from C (white bar), LP1 (gray
bar), LP2 (dark gray bar) and LP3 (black bar). Graph representing results obtained from
3-4 different western blots. Quantification of bands did not show any significant affect of
LP diet treatment on Pdxl protein level. One -way ANOVAs followed by Newman
Keuls was performed to compare C, LP1, LP2 and LP3 groups (n=3-4).
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Appendix 6: Western blot for insulin protein at d21 female offspring rats. (A)
Representative western blot of insulin protein levels and (3-Actin from pancreatic tissue of
\

d21 female groups. (B) Quantification of band intensity from C (white bar), LP1,2 (gray
bar) and LP3 (black bar). The graph represent results obtained from 3-4 different western
blots. One -way ANOVA statistical test did not show any significant changes in LP
(LP1,2, and LP3 groups as compared to C group. Data expressed as mean ± SEM as
relative to the internal control J3-Actin.
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Appendix 7: Western blot for GLUT2 protein from female offspring at d21. (A)
Representative western blot of GLUT2 protein levels and (3-Actin from pancreatic tissue
\

of d21 female groups from C (white bar), LP1,2 (gray bar) and LP3 (black bar). (B)
Graph representing results obtained from 3-4 different western blots. Quantification of
bands and one -way ANOVA statistical test did not show any significant affect of LP diet
treatment on G1UT2 protein level. Data expressed as mean ± SEM as relative to the
internal control P-Actin.
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Appendix 8: Western blot GK protein from female offspring at d21. (A)
Representative western blot for GK protein and P-Actin from pancreatic tissue of d21
female groups. (B) Quantification of band intensity from C (white bar), LP1,2 (gray bar)
\
and LP3 (black bar). Graph representing results of quantification obtained from 3-4
different western blots. One -way ANOVA statistical test did not show any significant
affect of LP diet treatment on GK protein level, n =3-4.
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Appendix 9: Western blot for insulin protein from female offspring at dl30. (A)
Representative western blot of insulin protein levels and p-Actin from pancreatic tissue
\

of dl30 female groups. (B) Quantification of band intensity from C (white bar), LP1
(gray bar), LP2 (dark gray bar) and LP3 (black bar). The graph represent results obtained
from 3-4 different western blots and quantification of bands did not show any significant
affect of LP diet treatment on insulin protein level. One -way ANOVAs followed by
Newman Keuls was performed to compare C, LP1 (, LP2 and LP3 groups (n=3-4)
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